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Summary 
Mechanical stimuli, including shear stress, contact surface rigidity, 
compaction force, cell organization, etc. has been found to affect cellular 
phenotypes, fate and behaviours. This thesis is dedicated to the application of 
mechanobiology principles to scale up a microfluidic proof-of-concept culture 
device into high throughput bioreactors by incorporating compaction to 
perfusion culture. The Scalable Compaction Bioreactor Array (SCBA) uses the 
thermoplastic material Polymethyl methacrylate (PMMA) as the main body to 
replace the PDMS used in the prototype in order to facilitate potential mass 
production. A first-of-its-kind “vertical flow” design has been adopted to 
control the compaction in a uniform and quantifiable manner in the multi-well 
array. Microporous membranes coated with collagen is used as the cell seeding 
substrate as well as the compaction generation. Hepatocytes, an important cell 
type utilized in drug toxicology testing platforms, were maintained with 
enhanced hepatic functions and polarities over a long term. Polarity re-
establishment was shown to be accelerated in the SCBA. Notably, cytoskeleton 
actin was found in distributions similar to in vivo liver and ex vivo tissue 
samples without any support of an ECM scaffold or overlays. This feature may 
help to culture cells in a 3D morphology without adsorption by supporting 
materials, which is highly sought after in drug testing applications. In 
conclusion, the SCBA is a promising modular high-throughput drug testing 
platform with adequate cell numbers per test, tight control over hepatocyte 
repolarization and intercellular interactions as well as improved cell functions 
for long-term in vitro cultures. 
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Chapter 1. Introduction 
Living cells dynamically respond to mechanical stimuli in the 
microenvironment in order to balance the changes in the physiological 
conditions and retain appropriate functions. [1] They can sense external 
mechanical forces or internally generated stress such as changes in membrane 
tension, cell shape, pressure difference, etc. and transmit corresponding 
biological signals via mechanotransduction mechanisms. [1], [2] For example, 
the organs inside mammalian abdomen constantly undergo the Intra-abdominal 
pressure (IAP) in the range of 5-7 mmHg for human and 1.5-4.5 mmHg (2 to 6 
cmH2O) for rats with fluctuation of less than 10mmHg due to animal movement 
or breath. [3], [4] So the applications of mechanobiology principles in in vitro 
cell culture may not only maintain or enhance cell viability, function and 
differentiation status, but also enable low-cost, high-throughput and robust 
platforms to be applied for drug testing, tissue engineering, regenerative 
medicine, etc. [5]–[7] 
Take liver cells, or hepatocytes, as an example. As the main cell type in 
liver, hepatocytes are responsible for detoxification, metabolism, bile and 
protein production and so on. [8] Physiologically, this type of cell forms cell 
blocks joined by tight junctions but supported with sophisticated and intricate 
vascular, bile ductal and lymphatic systems as they demand a high level of mass 
exchange to take in nutrients and oxygen and to excrete metabolic products and 
waste. During an in vitro culture, cells are normally attached to substrates or 
scaffolds without any functional vasculatures. A series of mechanical factors in 
the cell microenvironment, such as shear stress, rigidity of contact surface, 
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compaction force and cell organization structures, etc. will therefore need to be 
tuned so as to mimic the in vivo situation and maintain cell phenotypes, 
functions, fate and behaviours. [9]–[12] Through the study of tuning these 
mechanical stimuli to enhance the functionality and differentiation status of 
hepatocytes, these cells may then be cultured chronically for applications in 
drug toxicology, bio-artificial liver, real-time imaging, tissue engineering 
prototyping and biological mechanism studies. 
Previously, our laboratory has developed a PDMS-based 3D microfluidic 
channel-based cell culture system (3D-FCCS) to culture hepatocytes in a 3D 
perfusion system. [13], [14] In this device, the concept of “compaction” was 
demonstrated and proven to enhance hepatocyte polarities and functions. [15] 
However, many challenges remain in scaling up the chip for drug testing 
applications. Firstly, the chip material PDMS had an unsatisfactory surface 
property for applications like drug testing [16], also limiting the potential 
volume for mass production [17]. More than a decade ago the adsorption and 
absorption of PDMS to small molecules and drugs were already mentioned 
widely in literatures. [18]–[21] Hydrophobic molecules were found to be 
adopted through the porous surface into the bulk PDMS polymers. [18] And this 
adsorption could be greatly affected by changing of pH [18] as well as 
molecular component in the solution [20]. Even though surface modifications, 
e.g. plasma treatment, BSA coating, silanization and so on have been raised to 
reduce these effect, the changing of surface properties are not able to provide 
long term prevention but induce more complications of biocompatibility, 
evenness, time-dependant factors, etc. Therefore, it is preferable to replace 
PDMS with other materials when it comes to drug screening applications. 
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However, other factors like mass transfer efficiency and surface rigidity 
have to be considered when changing the core material from PDMS to silicon or 
polymers in order to achieve a similar cell performance. Besides, the 
compaction in the previous PDMS chip was applied manually, with no objective 
way to quantify or scale up into multi-wells. The new device should therefore 
include a more controlled system, while retaining the advantages of the PDMS 
chip such as a scaffold-less 3D culture and low shear stress perfusion even 
when scaled up. 
In this thesis, a novel strategy has been raised to control the mechanical 
microenvironment of hepatocytes in order to scale up the compaction culture 
device. A new vertical-flow multi-well bioreactor is proposed to generate 
compaction with low shear stress on cells in order to enhance the polarity re-
establishment and hepatic functions as well as maintaining in vivo-like 3D 
morphology in a 2D monolayer culture setup. This setup avoids the possible 
adsorption of drug compounds by the extracellular matrix (ECM) overlay or 
scaffold in prevalent 3D culture methods, which facilitate the application of 
drug testing. As a prototype, the main body of this device was built up using 
thermo-bonded Polymethyl methacrylate (PMMA), a polymer material 
confirmed with low water absorption ratio of 0.3–0.4% by weight [22] while 
PDMS with the ratio of 1 - 35% [23]. 
Other mechanical properties such as convection flow beneath micro-tissue, 
rigidity of substrate and scaffold are also explored to get a larger view of effect 
on the mechanical stimuli on in vitro cell culture. The whole thesis is based on a 
general hypothesis that the tuning of mechanical stimuli is able to generate 
an appropriate microenvironment for hepatocytes to rapidly re-establish 
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polarity, maintain in vivo-like 3D morphology and hepatic functions for 
drug testing applications. The specific aims to prove the hypothesis are listed 
below:  
1.1 Specific Aim 1: Explore mechanical modules to 
scale up the 3D in vitro culture microfluidic device 
 Troubleshooting in the silicon version 3D-mFCCS on the low mass 
transfer efficiency by adding convection flow under the 3D cultured 
hepatocytes.  
 Testing the relationship of bile canaliculi length with PDMS rigidity 
to look for optimum rigidity of substrates. 
 Correlating the hepatic maturation level in stem cell derived 
hepatocytes with rigidity in soft scaffold. 
1.2 Specific Aim 2. Design, fabrication and optimization 
of novel PMMA-based vertical-flow bioreactor 
Hypothesis: Vertical-flow design may filter out shear stress, generate even 
and controllable compaction onto cells in high throughput. 
 Design and fabricate the vertical-flow compaction bioreactor using 
thermoplastic PMMA. 
 Estimate the compaction pressure near cells on the microporous 
membrane  
 Optimize flow distributor to achieve even perfusion on a large 
culture area 
 Optimize cell seeding density in the bioreactor 
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 Investigate hepatic function of cells cultured in the device 
 Quantify polarity index to verify polarity acceleration resulted from 
compaction 
1.3 Specific Aim 3. Verify enhanced hepatocyte 
phenotypes under compaction in long term culture 
Hypothesis: The Scalable Compaction Bioreactor Array (SCBA) may 
maintain in vivo-like morphology, hepatic function and polarity in long term 
cultures. 
 Optimize the mechanical compaction by perfusion rate 
 Test long-term hepatic functions in a two-week culture period 
 Analyse polarity level improvement via co-localization percentage 
 Determine stress fiber distributions and compare with in vivo and ex 
vivo liver tissue samples 
 
Figure 1.1 Illustration on hepatocyte phenotype in the Scalable Compaction Bioreactor Array (SCBA) Compaction by vertical flow perfusion through microporous membrane induces in vivo-like cuboidal morphology of hepatocytes in monolayer culture, which enhances polarity and hepatic functions in long-term in vitro culture for drug testing applications. 
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1.4 Thesis organization 
This thesis is mainly made up of 6 chapters.  
Chapter 1 gives a brief introduction to this thesis. It comprises of the 
overview of specific aims as well as the organization of the whole thesis.  
Chapter 2 is the literature review to elaborate the impact of this work. The 
importance of mechanical stimuli on cells was reviewed. The reasons for 
choosing hepatocytes as the model cells and how the affected by the mechanical 
modules were discussed. The state-of-the-art in vitro culture systems for 
hepatocytes are also briefly studied. 
Chapter 3 reports the explorations to scale up the microfluidic device 
through the addition of a convection flow below 3D cultured hepatocytes in a 
silicon chip to improve cell viability, lowering of substrate rigidity to increase 
bile canaliculi growth as well as hepatocyte maturation level. 
Chapter 4 focuses mainly on the design, fabrication and optimization of 
the compaction bioreactor to reach a working prototype. The base of design, 
novelty and advantages of the vertical-flow perfusion as well as the features of 
the SCBA are explained in details. 
Chapter 5 presents proof that the bioreactor is capable of long term culture 
under optimized compaction and characterizes the enhanced hepatic polarities 
as well as in vivo-like morphologies. 
Chapter 6 concludes the thesis and provides recommendations for future 
work. 
 
   7
Chapter 2. Background and Significance 
2.1 Importance of mechanical stimuli on cells  
In Mechanobiology, we focus heavily on how physiological units such as 
cells and tissues actively respond to mechanical stimuli in their surrounding 
environments. [2] These biophysical stimuli include, but are not limited to: 
external forces, tissue volume constraints, substrate rigidity, cell organization 
structures (such as 2D or 3D), etc. [9]–[12] Though there is no data to quantify 
their contributions so far, lots of literature showed that changing cell 
organization from 2D to 3D dramatically changes the cell differentiation status. 
So 3D culture in vitro became more and more popular nowadays. 
 Besides, even though the term “mechanobiology” seems to be an inverse 
of the term “biomechanics”, there is a shift in focus from the field of mechanics 
to the field of biology, emphasizing on biological and physiological functions. 
[2] Under the umbrella of mechanobiology, much research has been done on 
how cells and tissues answer to mechanical stimuli. [2], [24] As shown in 
Figure 2.1A, in the microenvironment, there are a number of mechanical stimuli 
exerted onto cells. 
The earliest report on relationship of mechanical force with the tissue 
phenotype began with Pauwels in 1941, who raised a mechano-regulation 
model stating that combinations of different levels of shear stress (causing cell 
distortion) and the hydrostatic stress (changing cell volume) may lead to 
different differentiation directions like chondrogenesis or fibrosis. [25], [26] 
Following that, a series of research proved both numerically and experimentally 
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that mechanical force may guide the cell differentiation pathway into 
predictable lineages. [10], [11], [27], [28]  
The underline mechanisms on how cells respond to mechanical forces have 
been investigated from both the angles of biomimetic modelling and molecular 
level mechanotransduction. As shown in Figure 2.1B, cells may sense the 
stimuli from the surrounding environment, then transmit the signals all the way 
    
Perfusion of Media 
(Shear stress)
Cell-cell interconnection
Cell-Matrix/Substrate Interaction        (A) 
          (B) Figure 2.1 Affection on cells by mechanical microenvironment (A) Mechanical microenvironment of cells cultured in vitro (B) Mechanotransduction from mechanical microenvironment to nucleus. Reprint permitted with License Number 3784531316121] [24] 
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to the nucleus. This mechanotransduction process is essential in physiological 
regulations of cell shapes, functions and fates. [8], [9], [6], [10] For example, 
Wang et al has tested a panel of gene changes induced by mechanical 
compaction and found that the expression levels of Annexin A2 and HNF4a to 
be significantly changed due to mechanical compaction, which are both 
implicated in epithelial polarity formation.[15] Yet there is still large room of 
further investigation in order to connect the different factors in a clearer 
signalling pathway. 
 From another perspective, we can model how mechanical force changes 
the cell shape and interaction with neighbour cells in the tissue in order to 
predict the effect of mechanical stimuli on cells. When cells are isolated in a 
single cell form, they are generally spherical in shape so as to minimize their 
surface tension; however, when cells group together to form a tissue, they 
typically form polygonal shapes, and the contact surface are influenced by the 
interplay of both adhesion and cortical tension. [29] Through a 3D biomimetic 
model, it was proved that a threshold compression was essential to establish 
protein-mediated adhesion, and increasing the external pressure may strengthen 
the adhesion. (Figure 2.2) [31] More recently, it was found that the mechanical 
force balance between a cell and its neighbourhood may interplay with cell 
shapes and tissue morphogenesis. [32]  
The abovementioned application areas range from bone fracture healing, 
cardio-myogenic differentiation, myogenesis or osteogenesis of bone marrow 
stem cells (MSCs), etc. [10], [11], [28] Other than these, in vitro cultured liver 
cells are widely used in regenerative medicine, tissue engineering and drug 
testing platforms. Under experimental conditions, hepatocytes have been found 
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to alter their multicellular structure like bile canaliculi (BC) to enhance the 
hepatic functions when they experience mechanical stimuli such as surface 
binding affinity, aggregate size, substrate rigidity, mechanical compaction etc.  
[15], [33]–[35] This thesis chooses to focus on hepatocytes and hepatic lineage 
cells as the model cells for both the functional and applied study. 
 
2.2 Hepatocytes as the model cells 
In a mammalian body, the liver is the major detoxification and metabolic 
organ, with hepatocytes making up 60% of its cell components. [36] As 
hepatocytes actively metabolize exogenous substances, the demand for an 
adequate supply of nutrition and oxygen as well as timely removal of metabolic 
waste is higher than other cell types. [36], [37] This type of cell is thus 
vulnerable, and may easily lose liver-specific functions (such as albumin and 
urea production, cytochrome P450 activity, etc. [38]) when encountering stress 
such as oxygen tension[38], shear stress[39] and low polarity re-
establishment[40]. Therefore, except for viability, there are more important 
Figure 2.2 higher compression increases the adhesion patch sizes quantify this effect we bin the local inter-droplet forces and plot the corresponding average patch size as a function of the average force for all conditions (right diagram). In all cases, the increase of patch size with load force follows the model prediction of a square root law at high forces, but there is a pronounced deviation toward larger patches at low forces due to the onset of protein binding. [Reprint permitted by PNAS via email dated on 15 Jan 2016] [31] 
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factors to look into so as to evaluate the status and performances of hepatocytes, 
such as morphology, polarity, hepatic functions, etc. 
2.2.1. Liver Physiology 
Liver is the largest organ in mammalian animals. It occupies the upper-
right portion of the abdominal cavity, next to the stomach and directly under the 
diaphragm. Therefore, on top of the normal intra-abdominal pressure (IAP) at 
the range of 5-7 mmHg for human and 1.5-4.5 mmHg (2 to 6 cmH2O) for rats, 
the liver is subject to an additional pressure fluctuation of less than 10mmHg.  
[3], [4]  
The liver is also the primary organ for detoxification and metabolism; its 
functions include the metabolism of dietary factors (e.g. carbohydrate, fat and 
protein), the storage of nutrients (e.g. glycogen, iron, Vitamin A & B12), the 
detoxification of drugs and foreign compounds, and the secretion of bilirubin 
and bile, etc. [8] It is therefore highly active, occupying ~25% of cardiac output 
and 20% of oxygen consumption, and constitutes approximately 2.5% of the 
body weight. [41] The liver cells are inter-connected with a sophisticated 
vascular system (Figure 2.3), including the portal vein and the hepatic artery 
as the inputs of dual blood perfusion, sinusoids as the branching blood vessels 
directly facing hepatocytes, bile canaliculi starting from dead ends in between 
hepatocytes and finally pooling into bile ducts and accompanied with 
lymphatics and nerves going through the liver hilus to connect with other organs.  
[41], [42] Even though the ductal system maintains a high level of mass 
exchange with hepatocytes, these mesenchymal liver cells are susceptible to 
shear stress caused by pathogenic factors like hyperperfusion. [41]   
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2.2.2. Hepatocyte-specific morphology and stress fibers 
Hepatocytes are a type of specialized epithelial cells with a unique 
cuboidal morphology in vivo. A part of the membrane in between hepatocytes 
cave in to form a blind end of tubing called bile canaliculi (BC) and link 
together to form bile ducts in order to transport the bile and metabolic waste out 
of the liver. (Figure 2.3 for the model illustration and Figure 2.4A for the 
staining of actual liver samples). Much effort is taken to mimic this morphology 
when culturing hepatocytes in vitro so as to maintain proper hepatic functions as 
long as possible. A typical example of hepatocytes cultured in vitro for a few 
days is as in Figure 2.4B, where a large amount of stress fibers form between 
cells and substrate even though it was coated with ECM-like collagen. Some 
coatings or culture methods may help to reduce the amount of stress fibers and 
Figure 2.3 Microscopic structure of the liver [Reprint from "liver: structure of human liver". Illustration. Encyclopædia Britannica Online. Web. 09 Jan. 2016. http://www.britannica.com/science/human-digestive-system/images-videos/Microscopic-structure-of-the-liver-Liver-cells-or-hepatocytes-have/60419 with permission upon citation] [42] 
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make cells form sacs at the cell-cell contact (Figure 2.4C), which are similar to 
BC, but are not linked together to form a duct system. This form of BC and its 
link with hepatocytes will be further elaborated in Section 2.2.3. 
 
 Stress fibers are primarily composed with actin and myosin and 
commonly seen in attachment cultures. [43] They are formed in response to cell 
contraction status in non-muscle cells. [44], [45] In mammalian bodies, it is rare 
to see stress fibers (with the exception of hypertensive animals or around 
wounds); whereas during in vitro culture, prominent stress fibers appeared and 
the cells were flattened if they were attached to the substrate tightly. [45] This 
may be an indication that even though the cells pulled against the substrate, the 
rigid surface did not ruffle, which put the cells under mechanical tension [45], 
[46]. The thickness of stress fibers and the level of mechanical stress on the 
cells were found to be positively correlated. [45], [47] 
Figure 2.4 Morphology of hepatocytes in vivo and in vitro (A) Staining of F-actins (green) and nucleus (blue) of hepatocytes in vivo (frozen mice sample).  Scale bar extracted from the same panel of figures. (B) Staining of F-actins (red) of hepatocytes cultured in vitro on collagen coated culture plate for 3 days. (C) Staining of actins (red) of hepatocytes cultured in vitro as aggregates for 3 days. [Reprint permitted with License Numbers 3784660107295 and 3784651348539] [48], [168] 
B 
C 
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Specifically, for hepatocytes cultured in vitro, they entered a 
dedifferentiated morphology in which the cells are flattened out and a large 
amount of stress fibers were seen. [48] The dedifferentiation turned the 
hepatocytes into fibroblast-like cells, which resulted in a decrease in liver-
specific functions. [49] From this, we can see the importance of maintaining an 
in vivo-like morphology with minimal stress fibers in order to retain optimum 
hepatic functions. 
2.2.3. Polarity and bile canaliculi 
As a type of epitheliums, hepatocytes are highly polarized cells with clear 
differentiation between apical and basal lateral domains. (Figure 2.5A) Unique 
from other non-striated epithelia, hepatocytes have multiple narrow apical 
lumens, the bile canaliculi, and multiple basal surfaces facing endothelia like 
sinusoidal cells. [50] [51] When these cells are cultured in vitro, the vascular 
bile canaliculi in vivo deteriorate into enclosed sacs, releasing bile into culture 
media through periodical contraction (canalicular peristalsis). [52]  
The “form” of the membrane polarization follows the “function” that the 
intracellular pathways need to control the polarized trafficking of proteins and 
transport them out of the cells into the BC through cytoskeletal dynamics.[2][53] 
Among various transporters, MRP2 (Multidrug-resistance-associated protein 2) 
is involved to transport the glucuronidated, sulfated bile salts and conjugated 
bilirubin into bile. Therefore, it is a marker protein of the apical domain, which 
depicts where the BC is. [53] [54] In contrast, CD147 (cluster of differentiation 
147) is a matrix metalloprotein inducer targeting the basolateral domain of rat 
hepatocytes.[55] The location of these two marker proteins in polarized cells 
should be exclusive to each other whereas in non-polarized cells, MRP2 is 
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diffusive among all cytosol and cannot be clearly differentiated from the 
location of CD147. [56][57] (Figure 2.5B) These two markers are thus widely 
used in immunofluorescent staining on fixed samples to show polarity of rat 
hepatocytes. [58]–[61] 
2.2.4. Hepatic functions 
Hepatocytes have many functions in the human body, but a number of 
these functions are unique as compared to other cell types. These hepatocyte-
specific functions have been evaluated through a series of key assays over the 
years. For example, hepatocytes synthesize and secrete albumin into serum in 
both human and rats. [62] Therefore, albumin-producing cells are widely 
accepted as functioning hepatocytes.  [63] Additionally, the detoxification 
capability of hepatocytes includes the urea synthesis which converts ammonia 
into urea so as to clear them out of the cells and P450 activities which 
metabolize drugs through a series of enzymes. [64] As such, the amount of urea 
in the supernatant of culture media and levels of Cytochrome P450 enzymes 
(CYPs) are then an important index for metabolic competence of isolated or 
cultured hepatocytes.  [64], [65] 
(A) (B)  Figure 2.5 Polarity of hepatocytes (A)  Model of polarization of hepatocytes on the membrane [51] (B) MRP2/CD147 double-staining of hepatocytes in sandwich culture. [56] [Reprinted from Alcohol Res Health. 2006;29(4):291-5. http://pubs.niaaa.nih.gov/publications/arh294/291-295.htm with no permission requirements on the website and with the licence 3870250899549]   
   16
2.3 Mechanical stimuli affecting hepatocytes 
In lieu of the physiological features of hepatocytes, people have made 
much effort to mimic the in vivo environment for hepatocytes cultured in vitro 
in order to maintain both the differentiated status and function of this fragile 
type of cells as long as possible. A series of mechanical stimuli have been 
looked into throughout the years. [15], [57], [66]–[69] 
2.3.1. Shear stress 
Since hepatocytes are highly active cells with lots of protein production and 
chemical metabolism, the vascular system of bile canaliculi and sinusoids are 
developed in vivo to supply enough oxygen, nutrition and also to remove 
metabolic waste in time (Section 2.2.1 and 2.2.3). When these cells are cultured 
in vitro, no blood vessels are available and bile canaliculi keep pumping toxic 
waste into the media. [52] So perfusion becomes beneficial and necessary to 
A B 
C D 
Figure 2.6 Hepatocytes cultured in a microchip under various shear stress conditions (A-C) Phase-contrast microscope images for shear stress of (A) 0.14Pa (B) 1.2 Pa and (C) 3.6P. (D) Albumin synthesis by hepatocytes cultured in a microchip under various shear stress conditions. The line styles are classiﬁed by the shape of hepatocyte. Thick lines, normal shape; thin lines, stretched shape; dashed lines, spheroid shape [66] [Reprint permitted from http://iopscience.iop.org.libproxy1.nus.edu.sg/article/10.1088/0957-0233/17/12/S08 as NUS is a subscriber of the Open Access @ IOP] 
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keep a healthy and constant chemical microenvironment, which inevitably 
brings in the factor of shear stress. [66] As shown in Figure 2.6, increasing 
shear stress on hepatocytes could make the cells stretch the shape to a 
fibroblast-like cell shape (Figure 2.6B) or even kill the cells to make them round 
up (Figure 2.6C). The production of albumin also dropped as the shear stress 
increased (Figure 2.6D). Many perfusion culture devices therefore tried to use 
deep channels, filters, scaffolds, etc. in order to minimize the negative effect of 
shear stress, which will be elaborated in Section 2.4.1.  
2.3.2. 3D versus 2D 
As mentioned in Section 2.2.3, hepatocytes in vivo has multiple apical and 
basolateral domains. After evaluation by many laboratories among various 
extracellular matrix (ECM) support and culture conditions, three-dimensional 
(3D) culture was found to be better than 2D cultures in terms of re-
establishment of the complex polarity and retaining hepatic functions. [67] The 
morphologies from several 3D culture methods are shown in Figure 2.7. 
By assembling the hepatocytes into spheroids or micro-tissue aggregates, 
CYPs, albumin and urea productions were found to be enhanced. [68] However, 
the limitation of mass transfer via diffusion into the core restricts this kind of 
3D culture. Some modified spheroids, like 3D monolayer or tethered spheroid 
models, were established, which made the cells less affiliated to the substrate 
but stuck to each other to form small or flat aggregates. [57] [69] The limitation 
of these kinds of 3D culture lies in the difficulty for long term or large scale 
cultures. Some 3D culture used gel material as the support to mimic the contact 
of neighbor cells, such as the Matrigel and collagen gel sandwich culture. 
[70][71][69] Other systems uses scaffolds such as hollow fibers or packed beads 
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to support the cells in 3D. [67] Some even subjected the 3D cell structures 
under perfusion to achieve better mass transfer. [13] However, the supporting 
material may cause additional adsorption of compounds if these systems are 
applied for drug testing. For example, a low water soluble drug Testosterone 
may be absorbed 80-100% in collagen gel, PuraMatrix™ gel, Reinnervate 
Polystyrene scaffold as well as hydroxypropyl cellulose allyl sponge. [72] A 
better solution to maintain cells in 3D morphology is needed. 
2.3.3. Substrate rigidity 
Normal liver is a soft tissue with rigidity of 6 kPa or below [73] while the 
rigidity of conventional culture plates or coverslips are at order of GPa. [74] So 
a
d
 Figure 2.7 Morphologies of 3D cultured hepatocytes. Phase contrast images of (a) 3D monolayer [57] (b) spheroid, scale bar = 20µm [68] (c) Collagen gel sandwich [69] (d) micro-tissue under perfusion, scale bar =50 µm [13] No scale bar available on the original paper of (a) & (b). [Reprint permitted with License Numbers 3784681216318, 3785290634571, 3785290849898 and by Liebertpub via email dated on 12 Jan 2016] 
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there were numerous report suggesting that keeping a low rigidity of the cellular 
contact surface in substrate or coating may favor the maintenance or 
enhancement of hepatic differentiation levels or functions. [35] 
Primary hepatocytes have been shown to adopt a “rounded” phenotype on 
soft substrate with sensitive hepatic function enhancement to stimulation of 
growth factors; while they will “spread” on rigid substrate with loss of response 
to biochemical activation. [75] In a follow-up study, soft substrate may result in 
compact 3D spheroids of hepatocytes and achieve higher hepatic functions and 
marker gene expressions. [33] The hepatocyte behavior was even shown to be a 
function related to substrate rigidity and ligand density. (Figure 2.8) [33] 
Hepatocellular cell lines HepG2 were found to respond to substrate 
rigidity in cell attachment and growth on some coatings but not on others, 
suggesting other factors such as coating composition, cross-linking level, 
biofunctionality, surface charge and so on should also play important part to 
determine phenotypes. [35]  
 Figure 2.8 various hepatocellular phenomena as a function of substrate rigidity and density of the substrate presented ECM ligand [Reprint permitted with License Number 3785291353514] [33] 
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Possible mechanisms for hepatocytes to sense substrate rigidity could be 
mechanotransduction through cytoskeleton and focal adhesion molecules like 
nonmuscle myosin II, actomyosin network, integrins, etc. [76]. And all the 
molecules are involved to affect stem cell fate, differentiation and maturation 
via rigidity sensing as well. So hepatic differentiation of stem cells on different 
rigidity is also a typical tool to optimize substrate to keep cells in hepatocyte-
specific status in vitro. On rigidity of 0.1-1Mpa, hESC may express upregulated 
early hepatocyte markers like AFP and SERPINA1; while mature hepatocyte 
marker like TAT did not express at all. [77] Another experiment on rigidity 
range of 11-3500 Pa hydrogel showed that 220Pa scaffold favoured early stage 
hepatic differentiation from hepatic stellate cells into hepatoblasts both in gene 
and protein expression but the regulation is still complicated by other factors 
like compositions.[78] Therefore, control of rigidity on the cell-contact surface 
either through appropriate substrate or coating materials may assist to achieve 
higher hepatic functions and differentiation status. 
2.3.4. Mechanical compaction 
As mentioned in Section 2.1 and Figure 2.2, it was numerically modelled 
that mechanical compaction may change cell shape and strengthen cell-cell 
adhesion. The first experimental model to show its effect on hepatocytes, 
however, was reported in 2013 by members in our laboratory. [15] The 
designed experiment design involved using a pair of forceps to compress the 
ceiling of the elastic PDMS microchannel which was loaded with isolated 
primary hepatocytes. The constant compression helped to pack the cells tightly 
inside the microchannel, strengthening the cell-cell contact and accelerating the 
polarity re-establishment. (Figure 2.9) In compact cells, the MRP2 level was 
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constantly higher than non-compact cells, which meant that the polarity was 
also enhanced by compaction. (Figure 2.9C) Not surprisingly, hepatic functions 
such as albumin, urea, CYPs were also either enhanced or maintained. However, 
due to its size, the microchannel may only accommodate a few thousand cells 
(loading cell number 25000 cells/channel but there a large amount of cell loss 
during loading). In addition, the manual compression method makes it 
impossible to quantify the compaction or to scale up to multi-channels. Even 
 
 Figure 2.9 Compaction on hepatocytes in PDMS microchannel accelerated the polarity re-establishment Up: compaction on the ceiling of microchannel to pack hepatocytes tightly. Middle: FDA staining of hepatocytes with or without compaction. Bottom: quantification of polarity marker MRP2 to show the level of polarity re-establishment. [Reprint permitted with License Number 3785300312142] [15] 
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though it is a good proof of concept (POC), a better compaction culture device 
is needed to push the POC into application. 
 
2.4 In vitro culture devices for hepatocytes 
Even though numerous perfusion bioreactors and experimental models 
have been designed in the past several decades, [79]–[83] the challenge to 
maintain hepatic function, especially in long term cultures, still remains. 
Despite some trade-offs in different applications, the following three features 
are generally favourable in hepatocyte bioreactor designs. 
2.4.1. Perfusion culture 
In perfusion cultures, there is continuous mass transfer between the 
hepatocytes and the culture media in order to maintain a sustainable micro-
environment for hepatocytes. When a huge number of cells are cultured in 
applications such as bioartificial liver (BAL), hollow fibre membranes were 
widely used to immobilize either pure hepatocytes[79]–[81] their micro-
carriers[82] or scaffolds[83] so that the shear stress may be isolated during 
perfusion. (Figure 2.10A) However, the efficiency of mass transfer and dead 
volume was still a problem. Recently, Xia et al developed a stacked plate 
cylindrical bioreactor to perfuse hepatocytes double-sandwiched between two 
collagen layers. This was done to minimize dead volume and enhance mass 
transport. Eventually, 100 million cells were maintained for 7 days. [84] (Figure 
2.10B) 
When a smaller number of cells are needed for applications like 
mechanism study, real-time imaging and tissue engineering prototyping, 
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microfluidic chips were fabricated and tested. [85]–[89] Notably, the “organ-on-
a-chip” and “human-on-a-chip” has become a hot topic recently. [6], [90], [91] 
It is well known that the human body and its organs consist of many types of 
cells: these microfluidic chips connecting various cell chambers via perfusion 
flows may emulate the mass exchange and tissue interaction in an actual organ 
or body. Since the liver is such an important organ in the human body, 
hepatocytes were widely cultured as one of the components in these chips for 
the purpose of mimicking the liver function. [92], [93] (Figure 2.10C) 
In applications like drug discovery and testing, where a high-throughput is 
required, multi-well designs with microfluidic structures and/or micro-patterns 
on substratum were developed. [94]–[97] Domansky et al fabricated a 12-well 
array perfuse 3D scaffold preloaded with co-cultured liver cells. This reactor 
could maintain primary hepatocytes for 7 days, and extended the functional 
(A) (B)
(C) (D)  Figure 2.10 Perfusion culture devices in the literatures (A) Hollow fiber chamber for BAL application. [80] (B) stacked sandwich culture bioreactor for BAL application. [84] (C) multi-organ-chip with two microfluidic circuits in a PDMS-glass chip attached to a cover-plate and placed into a MOC holder (blue). [92] (D) RoboTox bioreactor for drug testing application. [95] [Reprint permitted with License Number 3870190812983, 3870190592859, 3870190956858, 3870191080788] 
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period of a non-parenchymal liver sinusoidal endothelial cell (LSEC) to 13 days. 
[94] Zhang et al developed a 96-well plate compliant bioreactor to perfuse cells 
sandwiched between silicon nitride (Si3N4) membranes and polyester (PET) 
film. The hepatic functions were enhanced for up to 14 days, and the cells were 
more sensitive to 6 compounds as compared to those in static culture.[95] 
(Figure 2.10D) 
 
2.4.2. Three-dimensional (3D) culture 
3D cultures have been found to enhance cell polarity re-establishment, 
reduce stress fibres and create a more in vivo-like local environment as 
compared to 2D cultures.[67] Many reports achieve 3D culture via confinement 
of hepatocyte aggregates in either an extracellular-matrix (ECM)[68], [70], [98], 
micro-patterns[99]–[101] or sandwich layers[102], [103], etc. However, the 
addition of ECM or extra layers may cause drug adsorption, which attenuates 
the accuracy of the test. Du et al developed a 3D monolayer model, which 
galactosylated the substratum surface so as to make the cells “stand” as in 3D 
culture, but without ECM support. [56], [57] Following his work, Xia et al 
created a tethered spheroid model to further enhance the hepatocyte 
differentiated functions.[69]  
However, as 3D cultures generate a larger dimension of cell colonies as 
compared to 2D, the demand for nutrition and oxygen exchange is even higher. 
Microfluidic chips were therefore developed to perfuse 3D micro tissues and 
achieve more relevant scale, dynamic control of micro-environment, and 
biomimetic patterning and designs. [90], [104] Toh et al developed a novel 3D 
microfluidic cell culture system (3D-mFCCS) using micro-pillar filters to trap 
   25
cells in the hydrophobic polydimethylsiloxane (PDMS) microchannels so as to 
create 3D micro-tissue in perfusion culture.[13], [14] On top of this device, 
Wang et al found that mechanical compaction force manually applied on the 
ceiling of the elastic PDMS chip may increase the packing density and contact 
of hepatocytes as well as accelerate bile canaliculi (BC) formation and 
maturation.[15] 
2.4.3. Long term culture 
As drug toxicity may have both acute and long-term effects, it is 
reasonable to test on models with prolonged cultivation. However, the majority 
of in vitro hepatocyte culture techniques only kept hepatic differentiated 
functions for 3-7 days. For this reason, chronic toxicity tests mainly rely on 
animal models. [105] Due to the high complexity and cost of animal 
experiments, and especially considering the unpredictability of shifting from 
animal tests to human trials, the demand for high-throughput cell models for 
chronic drug toxicology tests grew higher and higher to avoid compound failure 
at the expensive clinical trial phases. [105], [106] 
It was reported that micropatterns, co-cultures or ECM scaffolds may 
maintain certain hepatic functions for 12-14 days in static cultures[107]–[109]. 
Various perfusion reactors were also shown to enhance liver-specific functions, 
for instance, urea and albumin production, during cultures ranging from 9 days 
to 1 month.[110]–[113] Nevertheless, there are still no papers that report 
keeping primary hepatocytes in the long term without external support from 
either scaffolds or other cells. 
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2.5 Rationale and significance for this thesis 
Mechanobiology concepts to regulate cell phenotypes and functions have 
been demonstrated for the past tens of years but there is still big gap between 
proof-of-concept (POC) models with large scale application systems. Elicited 
by our in-house findings that mechanical compaction may help repolarization 
without the help of ECM in 3D perfusion microchannels[15], a multi-well 
bioreactor with incorporations of compaction in addition to perfusion culture is 
reported here in order to scale up the compaction POC model for potential drug 
testing purpose. To our knowledge, this is the first vertical flow designed 
bioreactor where the perfusate flows perpendicularly to cell culture membrane, 
with a micro-pore membrane acting as a shear stress filter. As parallel perfusion 
causes a concentration gradient from entrance to exit due to cell 
consumption[86], the local conditions might vary when the perfusion distance 
increases from micrometres to centimetres. Additionally, the high resistance of 
the micro-pore membrane for the perfusate to pass through builds up the 
pressure in the culture chamber, which serves as a controllable compaction onto 
the cells. In our setup, the hepatocytes showed accelerated polarity re-
establishment and exhibited 3D morphology and actin distribution as in vivo 
situation even though the cells were seeded as a 2D monolayer onto the 
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Chapter 3. Explorations of Mechanical 
Microenvironment Tunings to Scale up the 3D 
In-vitro Culture Microfluidic Device 
 Hepatocytes are considered as fragile cells because the hepatocyte-
specific differentiated status may be easily lost during in vitro culture even 
though the cells are still alive. Therefore, it is important to explore how to tune 
the microenvironment properly in order to maintain or enhance hepatic 
differentiation and function. The sections below probed into the mechanical 
properties of the microenvironment such as the mass transfer enhancement in 
3D perfusion culture and the rigidity tuning of substrate for bile canaliculi 
elongation as well as hepatic maturation level. The purpose of these 
explorations was to scale up the microfluidic chips for drug testing applications. 
 
3.1 Explore enhancement of mass transfer in 3D 
perfusion culture device  
3.1.1 Introduction 
PDMS has been widely used in microfluidic chip fabrication because of its 
biocompatibility, fidelity in soft lithography, modest working life and most 
importantly, convenience in prototyping. Our laboratory has developed a 
PDMS-based perfusion-culture device in microfluidic channels (3D-mFCCS) 
and demonstrated its efficacy in maintaining hepatocytes in 3D morphology and 
enhance the hepatic functions over 2D culture. [13] However, it is challenging 
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to scale up this chip for actual drug testing applications. The reasons are as 
follows: 
Firstly, there are production volume limitations intrinsically brought by 
the material PDMS. According to a statistic from manufacturer, PDMS is 
suitable for production of less than a hundred devices per year only; whereas 
polymer, for example, ranges from a thousand to a million and silicon may go 
beyond a million easily. (Figure A. 1) [17] Besides, there are more limits of 
feature definition in elastomer than rigid polymer or silicon such as aspect ratio 
and tolerance of dimension. And its unsatisfactory surface property such as 
hydrophobicity and adsorption of small molecules makes it not ideal for certain 
applications like drug testing. [16]  
Specific for 3D-mFCCS, the limited aspect ratio makes the filter pillars 
around the cell seeding channel unable to reach the full height of the channels, 
which lowered the efficiency of cell trapping because lots of cells escaped from 
the gap in between. So it became impossible to apply the chip in large scale or 
on expensive cells such as human hepatocytes or stem-cell differentiated cells.  
When switch from PDMS to silicon (Si), the aspect ratio and molecule 
adsorption issues may be well solved. However, a new problem was found to be 
a major obstacle that the high filter efficiency makes the cells to form compact 
micro-tissue but on the other hand, the perfused media could not reach the cells 
away from the pillars. Therefore, a mini-project targeting mass transport issues 
was done via incorporation of enhanced grid micro-features at the bottom of the 
micro-channel in order to increase the convection flow to the cells in the centre. 
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3.1.2 Methods and materials 
The perfusate of media was controlled by a syringe pump at the perfusion 
rate of 0.05 mL/hour and the tubing and valves (Upchurch Scientific, USA) 
(Figure 3.1A) were screwed onto the chip holder. This holder was designed and 
machined to provide a robust interface for the Si chip to connect with fluidic 
tubings using propylene carbonate (PC). (Figure 3.1B, right) The Si chip was 
fixed inside the holder with screws and a thin PDMS gasket in between was 
applied as a seal and protection of the fragile Si chip. (Figure 3.1B, left) 
The Si chips with deep channels and pillars was fabricated using classical 
Bosch process in Deep reactive-ion etching (DRIE) on 4-inch wafer. An array 
of pillars with 15 µm gap in between was created to occupy the whole 250 µm 
of channel height so that the filtering efficiency may be improved. After etching, 
SiO2 was deposited on the inner walls of micro-channels to render the surface 
hydrophilic and biocompatible. In order to further enhance the mass transport of 
culture media to cells in the inner part of 3D micro-tissue, shallow grid arrays 
with W10 µm × D10 µm dimensions were etched on the bottom of the cell 
seeding channel (Figure 3.1C-b). Chips with flat bottom were used as control 
(Figure 3.1C-a). 
For testing on cells, primary rat hepatocytes were isolated as stated in 
Section 4.3.3 and seeded into the chip using the same protocol stated in 
previous publication [13]. Then the perfusion culture started after the cell 
seeding channel was closed so that culture media may flow through the two 
media perfusion channels parallel to the cell seeding channel without disturbing 
the micro-tissue in the middle (Figure 3.1A & C). Live/dead staining was done 
after 1 to 3 days of culture by perfusion of media containing Calcium AM (5 
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μM, Invitrogen, USA) as an indicator of live cells and Propidium Iodide (PI, 50 
μg/mL, Molecular Probes, USA) and then imaging under confocal microscope 
(Olympus IX71). 
3.1.3 Results and discussions 
After cell seeding, the hepatocytes were packed inside the cell seeding 
channel and formed 3D micro-tissue structure (Figure 3.2A). As the cells were 
 Figure 3.1 3D cell culture on silicon perfusion chip (A) Whole view of perfusion culture setup. (B) Left: Top view of Silicon chip; Right: PC chip holder to interface Si chip and fluidic tubing. (C) Zoom in view of cell seeding channel in Si chips with two types of micro-features in the micro-channels: (a) With pillars surrounding the micro-channels but the bottom of channel is flat (control chip); (b) Grid-on-bottom: similar as (a) except that the bottom of channel is with grid of W10 µm × H10 µm. Both micro-channels are W200 µm × H100 µm for cells to form 3D micro-tissue. 
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packed tightly, the central part of the micro-tissue was difficult to get enough 
media through diffusion so that the cell death became severe even after 1 day of 
culture (Figure 3.2a). From the live/dead staining, the live cells only located at 
the thin layer near the pillars, indicating that the diffusion of media through the 
compact cells was very limited.  
From another perspective, this phenomenon may be a proof that compact 
cell aggregates were achieved in the Si chip. The pros of the compaction was 
elaborated in previous paper [15] as well as Section 2.3.4. The problem lies here 
was to increase the mass transfer and lower the cell death problem so as to 
enhance the cell viability in the Si chip. 
The micro-feature of shallow grids on the bottom was designed to increase 
the cross flow of perfused media beneath the seeding channel so as to improve 
 Figure 3.2 Live/dead staining of rat hepatocytes cultured in the Si chips with two different micro-features (A). Control chip with no grid on the bottom. Picture taken 1 day after seeding. (B). Chip with grid on the bottom. Picture taken 3 days after seeding. Green is the live staining with Calcein AM and red is the dead staining with PI. Merged photos are shown in the right column. White arrows depict the live colonies. Photos taken under 20X confocal microscope 
   32
the mass transfer. Figure 3.2b showed that after 3 days of culture, discrete live 
cell colonies were still seen in the middle of channels, even though there were 
certain cell deaths observed. This is an indication that the grids did increase the 
media supply to the cells in the middle of micro-tissue, possibly through 
convection flow on the bottom of cell seeding channel. However, due to the 
large height of seeding channel, the additional media supply at the bottom could 
not propagate far enough to achieve live cells uniformly all across the micro-
tissue. Therefore, unless micro-vascular systems could be created inside the 
compact micro-tissue, it would be more feasible to reduce the dimension of the 
micro-tissue so as to assure the efficiency of mass transfer. 
3.1.4 Conclusion and recommendations 
The 3D-mFCCS design was transferred from PDMS to Si chips with 
increased cell trapping efficiency to form compact 3D micro-tissue. The SiO2 
deposited in the Si chip makes the surface close to glass, which theoretically 
avoid adsorption of small molecules usually involved in drug testing. [19] 
However, there was limited medium supply to cells in the core of the compact 
micro-tissue, which caused severe death of the cells away from the pillar filter. 
So the enhanced micro-feature of shallow grid arrays was added to the bottom 
of the cell seeding channel to increase the mass transport to the compact 3D 
micro-tissue cultured above. It was shown that the viability of the cells could be 
improved mildly so that discrete live colonies were observed in the micro-tissue. 
However, the improvement is not ideal as some cell death were still observed 
for only 3 days of culture. Further enhancement is needed in the mass transport 
and robustness of the chip. One possible solution is to increase the mass 
transport efficiency to the whole micro-tissue. Another possibility is to bring 
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down the dimension of micro-tissue to reduce the diffusion length so that the 
exchange of oxygen and metabolites could be more in-time. 
 
3.2 Explore hepatic maturation level with scaffold 
rigidity tuning 
3.2.1. Introduction 
Liver is an organ with regenerative functions: even after 2/3 hepatectomy, 
it may still grow back to functional volume. [114] On one hand, there was no 
evidence showing that the reproduction was done by stem cells; on the other 
hand, mature hepatocytes in normal liver are generally quiescent with very 
limited proliferation capabilities. [115] So there must be a process causing 
hepatocytes to change their status, which is known as “dedifferentiation”. [116] 
Strong evidence has shown that hepatocytes are able to transform back to liver 
progenitor cells with suppressed hepatic functions but enhanced proliferation 
during in vitro culture. [116] Therefore, the research on hepatocyte culture may 
also be regarded as maintaining the “differentiation” status of hepatocytes in 
vitro as long as possible. 
When hepatocytes are differentiated from stem cells in vitro, the 
immaturity of resulted cells are obvious: after 20 days of differentiation, 
typically, the Hepatocyte-like Cells differentiated from Embryonic Stem (Hep-
ES) may reach only 5-10% of the function of primary hepatocytes. [117], [118]  
Study on how to further mature Hep-ES does not only potentially supply 
unlimited cell source for functional hepatocytes, but also shed lights on how to 
maintain the differentiation status of hepatocytes.  
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A widely accepted index to evaluate the maturation level of hepatocytes is 
calculating the expression ratio of CYP3A4/3A7: among the Cytochrome P450 
(CYPs) families, CYP3A7 was found to be the major form of CYP3A enzymes 
in human fetal liver whereas CYP3A4 was the major CYP3A in adults. [119] So 
the higher the index of CYP3A4/3A7, the more mature the hepatocytes may be. 
Our collaborator in University of Minnesota had shown the CYP3A4/3A7 may 
be enhanced by 2.7 folds in 3D culture than 2D when mature Hep-ES for 12 
more days after the 20-day differentiation (unpublished data). The term of 12-
day maturation was determined by the drop of expression level of AFP, ALB, 
etc. (bottom of Figure 3.3), which indicated that elongation of maturation 
beyond Day 32 did not help to increase the expression level.  





 Figure 3.3 Preliminary result of Hep-ES maturation in 3D spheroids comparing with 2D maturation on culture plate. Top: Process started with differentiation of hESCs for 20 days on 2D culture based on previously reported protocol (Figure 3.4B [117]) to get Hep-ES. Then the cells were harvested and for 3D spheroids and subject to further maturation for 12-15 days (until Day 32 to 35). Bottom: Gene expression of AFP and ALB (X axis: Day, Y axis: Log 2 expression relative to D20) as well as Alb protein secretion to show the enhancement of 3D maturation over 2D.  [125] [Reprint from http://online.liebertpub.com.libproxy1.nus.edu.sg/doi/abs/10.1089/scd.2013.0097?journalCode=scd with permission license exempted as reprint copy less than 100.] 
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could be enhanced via tuning the mechanical microenvironment like adopting 
the 3D morphology and choosing proper mechanical property of 3D scaffold. 
This mini-project took a step to explore the appropriate scaffold rigidity for 3D 
spheroid culture to improve level of hepatic maturation via tuning the rigidity of 
the cellulosic sponge to support the 3D spheroids against the maturation index 
CYP3A4/3A7.  
3.2.2. Methods and materials 
The overview of procedures in this exploration project is shown in Figure 
3.4A. The cellulosic sponge was fabricated using an improved protocol from 
our laboratory’s report earlier. [72] Firstly, 4g of dehydrated Hydroxypropyl 
cellulose (HPC) (MW=80,000 g/mol) was dissolved in 100mL anhydrous 
chloroform (water content less than 1%). While stirring, 2.095mL 98% allyl 
isocyanate and 1mL 95% dibutyltin dilaurate were added dropwise into the 
solution and continued to stir with Parafilm sealing for 48 hours at room 
temperature to cross link. The solution was then poured slowly into excess 
amount of anhydrous diethyl ether to precipitated as cloudy fibrous polymer and 
vacuum drying for 24 hours (The above chemicals were all purchased from 
Sigma Aldrich, Singapore).  Until this step, the key point was to prevent 
moisture entering the reaction, which required the water content of chemicals to 
be less than 1%, the vessels and forceps contacting with reaction to be kept in 
60 °C oven until use, and the vessels sealed tightly with lots of parafilm during 
stirring. After vacuum drying, the product should be in dry powder form 
otherwise the reaction may be judged as a fail. Then the powders were dissolved 
in deionized water (DI H2O) and dialyzed for 3 days in semi-permeable 
molecular-porous membrane tubing (Spectra/Por, USA) with running DI H2O. 
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The solution was then aliquoted to 50mL falcon tubes and freeze-dried 
overnight to get the intermediate product Hydroxypropyl cellulose Allyl (HA).  
The rigidity of the cellulosic sponge may be tuned then by changing the 
HA concentration. There were three HA concentrations tested here to screen for 
the optimum mechanical conditions: 10%, 8% and 5% (corresponding to 0.8, 8 
and 10 kPa rigidity). The rigidity of sponge corresponding to variation of HA 
concentration was measured in their hydrated status by rheometer as reported 
earlier [120]. The correspondent amount of HA was dissolved in DI H2O and 
aliquoted into glass tubes (Φ 6mm or 10mm). The tubes were kept in 40 °C 
water bath before and during γ radiation at the dose of 10 kGy/h for cross-
linking of 30 min (Gammacell 220, MDS Nordion, Canada). By then the HA 
was cross linked into sponge and the tubes were frozen in dry ice and broken 
mechanically to retrieve the sponge. The sponge was lastly cut by a Krumdieck 
tissue slicer (Alabama Research & Development, USA) into 1mm thick slices. 
And the native sponge was lyophilized to be prepared for galactosylation.  
 Galactosylation is to conjugate galactose to the native sponge so that 
hepatocytes may attach to the surface and form spheroids. For every 20 mL 
glass vial with 10mL acetone filled, 10 pieces of Φ 10 mm (double the number 
of sponge per unit volume for all Φ 6 mm ones.) were soaked and rinsed with 
acetone for 3 times in 20 min interval each. After last wash, 20 mM 1,1’ 
carbonyldiimidazole were added to the acetone and the glass vial was sealed 
with parafilm tightly to gently rotate on orbital shaker overnight at 4°C. On the 
following day, the sponges were equilibrated still room temperature for 30 min 
with parafilm sealed and then washed 3 times with acetone with 20-minute 
interval each. 2 mg/ml D-(+)-galactosamine was diluted in the carbonate 
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bicarbonate buffer (adjusted to pH 10) in the buffer and this galactose solution 
was immediately added at a volume of 1mL per Φ 10 mm sponge after the 
acetone was aspirated. Immediately shaking the bottle for 10 seconds to prevent 
imidazole fast hydrolysis and seal the vial with parafilm tightly to gently shake 
on orbital shaker at 4°C overnight again. On the following day, after 
equilibration to room temperature for 30 min, the galactose solution was 
replaced with firstly Dulbecco PBS (DPBS) and then DI H2O for 3 times at 20 
min interval each. Then the wet sponge was put at the center of each well of 
culture plate (24 well plate for Φ 10 mm and 48 well plate for Φ 6mm sponges) 
to lyophilize for 1 day. The plate with sponge was then sealed with parafilm and 
sterilized with γ irradiate for 8 min to facilitate cell seeding.  
The cells Hep-ES was differentiated from hESC H9 cell line (WiCell 
Research Institute, Madison, USA) with 4 step protocol reported earlier [117] 
The differentiation media was made from basil media supplemented with the 
corresponding growth factors in the 4 stages shown in Figure 3.4B as well as 
2% fetal bovine serum (FBS) in Stage 1 (Day 1-6) and 0.5% FBS in latter stages 
(Day 6-20). The basal media was composed of 60% DMEM-low glucose 
(Gibco, Carlsbad, CA, USA), 40% MCDB-201-water (Sigma), 0.25X Linoleic-
Acid-Bovine serum albumin (LA-BSA) (Sigma), 0.25× Insulin-transferrin-
selenium(ITS) (Sigma), 100 IU/mL Penicillin and 100 g/mL Streptomycin 
(Cellgro), 0.1 mM L-Ascorbic Acid (Sigma) and 1 M Dexamethasone (Sigma) 
and 110 M 2-mercaptoethanol (Gibco). At Day 20, Hep-ES was harvested 
using incubation at 37 °C with 2X Gibco TripLE Select (Life Technologies, 
Denmark) for 5 min to trypsinize gently into single cells. This step may be 
repeated for 2 to 3 times for thorough trypsinization and all harvested cells were 
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combined to pass through a 70 m strainer to prevent clogs or impurities. The 
flow-through was pelleted at 1000 rpm for 5 min at 4°C and re-suspended in 1 
to 2 mL differentiation basil media supplemented with 10 M ROCK inhibitor 
(ROCki) Y27632 (Calbiochem, Billerica, MA, USA), rmFollistatin-288 
(100ng/ml), rhHGF (HGF) (20 ng/ml) and with or without rhOncostatin M 
(OSM) (40ng/ml) to reach a final concentration of 1.8 or 5.5 million cells/mL, 
according to the yield and sponge size (0.1 million per Φ6 mm and 0.3 million 
per Φ10 mm sponge). 55 µL or 18 µL cell suspension was added on both sides 
of Φ 10mm or Φ 6 mm sponge, respectively. 20-30 µL more differentiation 
media per Φ 10mm sponge may be added to wet the sponge thoroughly without 
over flow to facilitate cell migration (this step was skipped for Φ 6 mm sponge 
Vary concentration of HA to fabricate sponge
Galactosylate sponge with different rigidity
Differentiate hESC to hepatocyte-like cellsD0-D20
Maturate hepatocyte-like cells D21-D32
Test hepatic maturation markers via qPCR
Harvest & seed
             (A) 
(B)  Figure 3.4. Maturation of hESC derived hepatocytes in sponge with various rigidities (A) Overview of procedures. (B)Four-stage protocol to differentiate hESC into Hep-ES (D0-D20) [117] [Copyright: © 2010 Roelandt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.]  
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to prevent over flow). Incubate the sponge in CO2 incubator for 45 min so that 
cells may be settle down. Then 500 µL/well media (with ROCKi) was slowly 
topped up in 24 well plate (or 300 µL/well in 48 well plate) from side of well 
without flushing the cells out of sponge. Spheroids should be formed on the 
following day and differentiation media without ROCKi was added every two 
days throughout the maturation process. 
At Day 32, cells were lysed and mRNA isolation was performed using 
RNeasy Micro-kit (Qiagen, Hilden, Germany). RLT plus buffer in the Qiagen 
kit was used for cell lysis and the solution may be stored at -80°C until mRNA 
extraction. On the day of mRNA isolation, the frozen lysis sample should be 
thawed using 37 °C water bath, following the steps of thawing cryo-preserved 
cells in order to prevent RNA degradation as much as possible. After isolation, 
the mRNA elution was kept on ice and the total amount of mRNA was 
quantified using NanoDropTM ND-1000 Spectrophotometer and converted to 
cDNA using High Capacity RNA-to-cDNA kit (Applied Biosystems, USA). 
The obtained cDNA may be stored at -20 °C until qPCR was done. 
LightCycler® 480 SYBR Green I Master (Roche, USA) was used for qPCR and 
the reaction mix were loaded into 96-well PCR and sealed Plate (Nacalai, USA). 
Primers were bought from GeneCopoeia, Inc. (Rockville, MD, USA). 7000 Fast 
Real-Time PCR System (Applied Biosystems, USA) was used to perform the 
qPCR. The expression levels of all marker genes were normalized to 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to 
account for differences in cell numbers.  
3.2.3. Results and discussions 
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In order to explore the relationship of hepatic maturation level with 






 Figure 3.6 Maturation of Hep-ES in cellulosic sponge with different rigidity.  Hep-ES were harvested at Day 20 of differentiation and seeded into the sponge. On Day 21 they form spheroids and kept the morphology until Day 32. For 2D control, the Hep-ES were harvested using same protocol and re-plated onto Matrigel for further maturation. Pictures taken from 10X PH optical microscope. 
Scaffold Type E (KPa) in hydrated state13% HA 10
10% HA 8
5% HA 0.8 (A) (B)  Figure 3.5 Tuning the rigidity of cellulosic sponge by varying the HA concentration. (A) The rigidity corresponding to variation of HA concentration measured by rheometer. (B) Trial to lower the HA concentration to 2.5% and resulted in dissolved sponge without proper mechanical strength for slicing or cell seeding (bottle on the left). HA from same batch may form sponge properly in higher HA concentration (bottle on the right took 10% as an example) 
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first. From previous result, the rigidity of cellulosic sponge may be tuned via 
changing the HA concentration before γ radiation crosslinking and the 
correspondent rigidity with HA percentage is shown as Figure 3.5A. When HA 
concentration was increased from 10% to 13%, the rigidity did not change much 
(from 8 to 10kPa), showing a plateau of rigidity increase by increasing the HA 
concentration. However, when the HA concentration was decrease from 10% to 
5%, the sponge rigidity may be decreased apparently from 8 to 0.8 kPa. When 
further decrease the HA concentration to 2.5%, the sponge was not able to 
cross-link into fixed shape and the poor mechanical strength made it impossible 
for handling like slicing, relocating or cell seeding. (Figure 3.5B) Hence 5% 
may be the lower limit of HA concentration to form a proper sponge. In many 
prevailing papers, the accurate value of liver rigidity was not determined but 
generally the elastic modulus below 6 kPa was considered as normal. [73] Some 
reports mentioned that the rigidity inside cell layers could range from 0.5 to 5 
kPa, [121] So tuning sponge rigidity from 0.8 to 8 kPa could well cover the in 
vivo rigidity range and 5%, 8% and 10% HA concentration were chosen for the 
following experiments. 
After differentiation for 20 days, the harvested Hep-ES were able to form 
spheroids on the cellulosic sponge conjugated with galactose, which weakly 
bind to ASGPR receptor on the membranes of hepatocytes. [72] In contrast, 
hESCs without differentiation could not attach to the sponge nor form spheroids 
(data not shown). The spheroids were able to maintain throughout the 12-day 
maturation process (Figure 3.6). In contrast, the Hep-ES on 2D culture with 
rigid substrate showed stretched cell morphologies with elongated cell shape 
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and lots of filopodias, which indicated the cells were undergone stress and 
became fibroblast-like cells.  
In an improved protocol, OSM was added to the media, which was 
supposed to stimulate the development of E-cadherin-based adherens junctions 
in foetal hepatocytes, which should help the formation of spheroids as well. 
[122]–[124] From the phase contrast image, when OSM was added, the 
spheroids appeared more compact and round in shape comparing with the OSM 










 Figure 3.7 Hep-ES maturation with or without addition of OSM. Pictures taken under 10X Phase contrast optical microscope. 
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cells formed more aligned and tight colonies so that less filapodia was seen. 
(Figure 3.7) 
The expression levels of hepatic marker genes of the obtained cells were 
then tested using reverse transcript qPCR. As shown in Figure 3.8, when OSM 
was added to the differentiation media, all the hepatocyte-specific gene levels 
were higher than the cells differentiated without OSM. And there were 
significant increases of markers CYP3A4, HNF4a and AAT for cells 
differentiated in sponge over the 2D control, indicating the advantage of 
(A)
(B)  Figure 3.8 Hepatic marker gene expression after maturation (A) No OSM added (B) OSM added to the differentiation and maturation media. Student’s T-test was performed. Single line bar indicates the P value <0.05 and double line bar showed the P value <0.1 
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maturation in 3D culture using scaffolds. [125] [126] When look at individual 
culture conditions, 5%HA sponge outperforms all other substrate in these 
markers. 
For maturation level, the level of both CYP3A4 and CYP3A7 were 
analysed. Generally speaking, when the rigidity of sponge lowered, the 
expression of CYP3A4 decreased and the CYP3A7 increased (Figure 3.9A), 
which resulted in the increase of maturation index CYP3A4/3A7 (Figure 3.9B). 
However, the increase of CYP3A4/3A7 was less than 2 folds, indicating that the 
maturation level was not significantly increased by varying the rigidity from 
8kPa to 0.8kPa. The reason was that seeding cells in sponge did not only 
(A)
(B)  Figure 3.9 Number of fold increase of maturation markers over 2D control (A) Increase of folds in CYP3A4 and CYP3A7 over 2D control. (B) Increase of folds in CYP3A4/3A7 over 2D control. 
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increase the mature hepatocyte marker CYP3A4 but also increased the foetal 
hepatocyte marker CYP3A7, making the change of 3A4/3A7 ratio less 
significant. Noted that the pathways in humans generally take between 0.5 to 12 
years to achieve maturity of hepatic functions, [127], [128] the factors affecting 
maturation level should be far more beyond rigidity and the challenge to obtain 
mature cells in vitro may remain for a long time. 
3.2.4. Conclusions and recommendations 
Nowadays there were increasing evidence demonstrating that mechanical 
stimuli such as substrate rigidity may play a key role to determine cell fate in 
many lineages. [129]–[131] Due to the special “dedifferentiation” feature of 
hepatocytes, the key challenge to maintain the hepatic function in vitro is on 
how to keep their differentiation status. So this mini-project probed into the 
relationship of hepatic differentiation level with rigidity of scaffold in 3D 
culture.  
It was shown that by changing the concentration of intermediate polymer 
HA before cross-linking into sponge, the rigidity may be tuned from 10kPa 
down to 0.8kPa. After galactose conjugation onto the sponge, Hep-ES may form 
spheroids and maintain until end of 12-day maturation. As Oncostatin M (OSM) 
was suggested to increase E-cadherin-based adherens junctions and lead to the 
maturation of hepatocytes in the late prenatal period in the developing livers 
[122]–[124], [132], the cell morphology and expression level of hepatocyte-
specific markers were compared between with and without OSM addition. The 
data supported that OSM helped to achieve compact colonies and increase 
hepatic marker gene expressions. A bunch of hepatic differentiation genes were 
also shown to increase significantly in sponge comparing with 2D culture. 
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However, there was no significant difference of maturation index CYP3A4/3A7 
(less than 2 folds), indicating there shall be more factors other than rigidity in 
the microenvironment to control maturity level of hepatocytes. Similar 
complications were also reported in HepG2 cells before. [35] 
 
3.3 Explore the relationship of bile canaliculi elongation 
with substratum rigidity 
3.3.1. Introduction 
The rigidity (also named as stiffness) value of 6kPa and below for liver is 
considered as normal without ongoing diseases. [73] But when liver cells are 
cultured in vitro, the rigidities of plastic culture plate, silicon chips or other rigid 
substrate are on the order of GPa, which makes the cells undergo very different 
contact surface as compared to in vivo. [74] Even though some previous models 
coated their surface with ECM, whether the rigidity can be brought down to the 
level in vivo still remains uncertain, not to mention that ECM could be worn out 
as culture time extended. This is one of the reasons why in vitro cultured 
hepatocytes get flattened on their substrate with heavy stress fibers developed, 
which causes the loss of polarities and hepatic differentiated status to become 
fibroblast-like cells.  
 On the other hand, similar to the situation in vivo that bile canaliculi (BC) 
can develop in between hepatocytes and elongate to tubings eventually 
connected to bile ducts, bile canaliculi in polarized hepatocytes cultured in vitro 
may also remodel to tubing-like structures. The length of BC is an indicator of 
polarity establishment and was shown to closely related with adherent junction 
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molecules like Rho kinase, myosin-II, MAPK and Cadehrin. [133][134] Hence 
it is reasonable to hypothesize that substrate rigidity may be a factor to affect 
BC development and this mini-project tried to test whether there is correlation 
between BC elongation and rigidity of contact surface to hepatocytes. If a clear 
relationship could be found, the optimum rigidity of substrate could be picked 
up to enhance the polarity re-establishment in vitro. 
3.3.2. Methods and materials 
The rigidities of PDMS (Sylgard 184, Corning USA) were adjusted by 
changing the ratio of polymer (Part A) to hardener (Part B). The ratio of 75:1 
corresponded to the rigidity of 5kPa whereas 10:1 to 2MPa (established 
protocol in-house). The PDMS was mixed freshly and spin-coated on Φ15mm 
coverslips at the optimized condition of 2000 rpm, 3min. Then the PDMS was 
cured at 70 °C for 4 hours.  
In order to facilitate cell attachment on PDMS, several coating methods 
were tested: with or without O2 plasma, coated with collagen gel or fibronectin. 
Eventually fibronectin coating without O2 plasma was chosen as the coating 
material so as to ensure that hepatocytes sense the rigidity of PDMS rather than 
other ECM gel or affected by plasma-treated surface. So before seeding, the 
PDMS was washed 3 times with PBS and coated with 1mg/mL fibronectin 
diluted in PBS on 4 °C overnight. [135] 
Primary hepatocytes were freshly isolated from male Wistar rats (250-
300g) and seeded on the next day. 0.2 million cells per well of 24 well plate was 
pipetted from the suspension and added to plenty of sterile PBS to wash away 
DMEM based media for isolation. The cells were spin down at 80g, 1min 
centrifugation and re-suspended in Rat-Hep-WE in a volume of 500 µL per well. 
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Then the PDMS was taken out from the 4 °C fridge and washed 3 times with 
PBS to remove the redundant fibronectin. After aspiration of the PBS, the 
hepatocyte suspension in Rat-Hep-WE was seeded onto the PDMS in a dot-by-
dot scanning manner and kept still for 2 to 3 minutes for the cells to settle down. 
When there were no regions of cell congestion found in the wells, the culture 
plate was moved very gently from the biosafety cabinet into the CO2 incubator. 
In order to achieve good imaging quality, the seeded cells were washed once 
with PBS or Rat-Hep-WE and changed to fresh media 4 hours after seeding so 
that unattached cells could be removed in time. 
On the next day, collagen overlay was prepared by diluting 1.5mg/mL 






 Figure 3.10 Morphology of hepatocytes cultured on PDMS with different rigidities and with or without O2 plasma treatment.  All the photos were taken under 10X phase contrast optical microscope. 
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Each well was washed once with 1mL PBS and added with 250 µL collagen 
overlay to gel for 3 hours at 37°C CO2 incubator. Then 0.5mL Rat-Hep-WE was 
added to each well on top of the overlay and incubated for 1 hour to dissolve 
any possible deleterious substance during gelation. Lastly fresh Rat-Hep-WE 
was changed for 0.5mL/well and cells were cultured for 3 days with media 
change daily and phase contrast pictures taken. 
On Day 3, the cells were fixed for IF staining with similar procedures 
stated in Section 5.2.4. The markers chosen were Phalloidin (Actin dye, 1:200 
dilution, Alexa Fluor 488), rabbit anti-MRP2 (M8316, Sigma, USA, 1:200 
dilution). The secondary antibodies used were at 1:200 for Alexa Fluor 555 
Donkey anti-Rabbit IgG (H + L) (A31572, Invitrogen, USA). The PDMS 
samples were then mounted to microscopic cover slips and sent for confocal 
imaging. Imaging processing and quantification were done using ImageJ. 
3.3.3. Results and discussions 
One interesting phenomenon shown in this project was that hepatocytes 
did show rigidity relevant morphology but only when the substrates were not 
treated with plasma prior to cell seeding. As shown in the first 2 rows of Figure 
3.10, when there was no plasma treatment, the hepatocyte colonies on soft 
substrate (75:1, 5kPa) displayed a more round-up and standing morphology 
with smaller sizes; whereas those colonies on harder substrate (10:1, 2MPa) was 
more flat and stretched with bigger sizes. After plasma treatment, in contrast, 
the difference of substrate rigidities was covered: hepatocytes formed confluent 
colonies on both types of PDMS and the cells were as flattened as those seeded 
on rigid culture plate (Last two rows of Figure 3.10). Therefore, plasma 
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treatment of substrate should not be included if effect of rigidity needed to be 
studied. 
The cells cultured on fibronectin coated PDMS without plasma were then 
fixed and stained for polarity markers MRP2 and cytoskeleton marker Actins. A 
typical bile canaliculus in collagen gel sandwich culture should be tube-like 
structure with contour of Actin and filling of MRP2, which is shown in Figure 
3.11A & B. However, the BCs on 2MPa PDMS displayed short yet swelling BC 
shapes while the ones of 5kPa appeared elongated and thin. The histogram of 
BC lengths in Figure 3.11C confirmed the observation. There was more 
frequency of BC to fall in the length range of 0-100 µm on the 2MPa substrate 
(A) (B)
(C)
 Figure 3.11 Bile canaliculi growth on PDMS with different rigidity (A-B) IF staining of BC on PDMS with rigidity (A) 2MPa (Hardener to polymer ratio is 1 to10) and (B) 5kPa (1 to 75). Green is actin, red is MRP2 and blue is DAPI. (C) Histogram of BC length counting in the range interval of 100um. (n=300-500). Scale bar = 50µm  
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than 5kPa; whereas in the length range of 300-400 µm and longer, there was 
more long BCs on 5kPa than 2Mpa substrate.  
This phenomenon may be well explained by a recent paper done in our lab. 
[136] According to Li et al, the extension of bile canaliculi tubes was driven 
along the direction with minimal tension. Logically soft substrate provides more 
allowance for cells to grab via focal adhesion, which result in less tension for 
attached cells. The colonies in the first two rows of Figure 3.10 on 5kPa 
substrate showed much rounded-up shape while those on 2MPa substrate 
showed stretched angles on the periphery of colonies, which right proved the 
less tension of the soft substrate to the hepatocytes. Therefore, the bile 
canaliculi were more elongated on 5kPa than the 2MPa PDMS can be caused by 
the less tension of the soft substrate. 
3.3.4. Conclusions and recommendations 
Rigidity of the substrate affect the phenotype of cells cultured in vitro. [74] 
As liver is a soft tissue, conventional culture plate or rigid substrate cannot 
provide a biomimetic microenvironment for the attached hepatocytes, which 
result in lots of stress on the cells and loss of polarity and hepatic functions. 
This mini project tried to change the substrate rigidity to that of the liver tissue 
(5kPa) and compare the BC elongation with the rigid one (2MPa) with exactly 
the same material (PDMS) but just different ratio of polymer to hardener. 
Through statistics of BC lengths, it was found that the BCs were more elongated 
on the soft substrate; whereas the rigid one resulted in lots of short yet swelled 
BCs. This phenomenon is in accordance with the recent report that BCs 
extension is in favored on the less tensioned direction. [136] Putting together 
with the data in Section 3.2 showing that soft scaffold slightly increased the 
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level of hepatic maturation and the data in this section that the soft substrate 
slightly facilitate the elongation of bile canaliculi, it is recommended to choose 
a soft substrate with similar rigidity to liver tissue (6kPa and below) where 
applicable. And in the situation when it is not possible to bring down substrate 
rigidity, ECM coating like collagen on top of the substrate may be a better 
choice than other expensive coatings like RGD, fibronectin, etc. because it well 
supports hepatocytes with defined biochemical integrant and low rigidity 
similar to liver tissue. 
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Chapter 4. Design, Fabrication and 
Optimization of the Scalable Compaction 
Bioreactor Array 
4.1. Background 
With the development of in vitro culture of hepatocytes since 1980s, there 
have been numerous models and reactors coming out to cater for various 
applications like bioartificial liver (BAL), drug toxicology testing, therapeutic 
development and tissue engineering. [37], [105], [137] Due to the high 
metabolism and detoxification nature of hepatocytes, it is preferable to use a 
perfusion culture system to ensure an adequate nutrition and oxygen supply as 
well as fast waste removal. [90], [104] However, the shear stress created during 
perfusion may damage the functionality or even compromise the viability of the 
hepatocytes. [13], [86] An essential consideration of a perfusion bioreactor is to 
find a balance between the perfusion velocity and mass exchange rate is 
therefore critical to a bioreactor’s functionality.  
The 3D-mFCCS our lab has developed made the first step to achieve this 
balance by integrating pillar filters around the cell seeding channel so that the 
loading cells may be well trapped and the shear stress can be filtered out during 
the perfusion later on. [13], [14] And there is an improved protocol by 
incorporating compaction force on top of perfusion culture to achieve better 
hepatocyte performances. [15] However, after a few rounds of explorations to 
scale up the PDMS chip (Chapter 4), problem like mass transfer inefficiency 
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(Section 3.1), low throughput [14], uncontrollable manual compaction [15], 
limited accommodation of cells [15] and so on still remained unsolved.  
Therefore, a Scalable Compaction Bioreactor Array (SCBA) has been 
proposed to use biocompatible thermoplastic polymethyl methacrylate (PMMA) 
for potential low-cost and robust mass production. A novel “vertical-flow” 
design was adopted in SCBA with the integration of microporous membranes as 
the shear stress filter, and the expansion of flow path area to a lower perfusion 
velocity while keeping a large culture area. The optimized perfusion device is 
expected to improve hepatic functions as compared to static cultures, and thus 
becoming a potential platform for drug testing applications. 
4.2. Principles of the design 
4.2.1 State of the art: designs to filter out shear stress 
As shear stress during perfusion may damage the functionality or even 
viability of hepatocytes, [13], [86] an essential component of a perfusion 
bioreactor is the shear stress filter, which minimizes the risk of shear stress 
damage when the perfusate passes by the cells while still maintaining optimum 
levels of mass exchange. The prevalent papers discussing micro-filters are 
primarily for the separation of certain types of particles or cells out from the 
solution. [138][139] However, from a different point of view, shear stress is 
caused by the continuous flow of perfusate onto the cells, with the materials in a 
liquid form. The separation micro-filters are therefore also applicable for use as 
shear stress filters. [140][141] 
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Figure 4.1 Four types of filter designs (a)Weir (b) Pillar (c) Cross-flow (d) Membrane filter. [Reprint permitted with License Number 3785451157098] [138]  In general, there are four types of micro-filter designs, i.e. Weir, pillar, 
cross-flow and membrane filters [138]. When looking at their effect on shear 
stress filtering, their flow velocity distribution becomes important. (Figure 4.1) 
These types of filters can be described as follows: (1) The Weir filter sets a 
sudden restraint of cross-section area of the flow path so that the flow resistance 
increases and the velocity distribution lowers in some areas where cells may be 
seeded and protected (such as the light orange areas in Figure 4.1a). However, 
there are large “dead volume” regions where perfusion velocity becomes zero 
and mass exchange is paralyzed. This will cause no perfusion for the cells in 
those regions; the cells in the localized area are subject to conditions similar to 
static cultures, and may result in damage to the cells during extended culture 
times. Additionally, there are large changes in the velocity profile within a small 
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area near the weir, which translates to an extremely unstable microenvironment 
for the cells inside the bioreactor. The weir filter is therefore not a good choice. 
(2) A Pillar filter sets an array of weirs on the flow path so as to shrink the 
areas of dead volume, achieve more even velocity distributions and lower the 
risk of clogging. Since the perfusate goes through all the pillars, the mass 
exchange is efficient. However, as the cross section area of the pillar array is at 
the micron level, the flow velocity could still be significantly high even when 
flow rates are maintained at the lower extremes of the syringe pump (as shown 
in the red zone of Figure 4.1b), making it still difficult to lower shear stress at 
the affected regions. Besides, due to limitations in fabrication and the 
mechanical strength of materials, pillar filters are often only used in micro 
devices, and is difficult to scale up. (3) When the flow direction is parallel to the 
pillars, it becomes a cross-flow filter. As the flow resistance of the pillars is 
larger than the microchannel, most of the flows will not go through the pillars, 
but rather flow out from the microchannel (Figure 4.1c left side). This is a way 
to lower the velocity across the filter and protect the cells seeded on the other 
side of the filter. However, in this case, the mass exchange rate is affected, and 
so to compensate for that, the total flow rate has to be increased. A method to 
balance shear stress and mass transport is to make a vector component of the 
main stream flow towards the pillars (Figure 4.1c right side). Even though this 
is an effective method adopted by many working models, the inherent 
shortcomings lie in the concentration gradient along the flow as well as the 
difficulty of scaling up the microfilters. (4) A Membrane filter integrates a 
porous membrane in  the flow path and either allows the perfusate to pass 
through (dead-end filtration) or partially pass through (cross-flow filtration) 
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[139] (Figure 4.1d). Its advantage over the pillar and cross-flow filters lie in the 
ease of integrating large area membranes with the purpose of scaling up the 
bioreactor. In cross-flow filtration membranes, however, even though the shear 
stress is minimal in most set-ups, the concentration and velocity gradient may 
still cause an inconsistency across the culture area on the other side of the filter 
(Figure 4.1d insert). For a dead-end filtration model, the high resistance of the 
membrane may cause pressure build-up inside the enclosed culture chamber, 
making it a challenge to integrate a large area membrane without running a risk 
of leakage or breakage. Besides, in order to achieve an even dissipation of flow 
after the large-area filter when the entrance is small in diameter, a flow 
distributor is needed before the membrane.  
4.2.2 Advantages of vertical-flow bioreactor 
Inspired by the pros and cons of existing filters on shear stress filtering, I 
would like to present a novel “vertical-flow” perfusion culture bioreactor for 
hepatocyte culture, for use in drug testing applications. To the best of our 
knowledge, this is the first of its kind design to date. This design addresses 
many of the problems in previous designs, and has a long list of advantages. 
Firstly, the problem of concentration gradients in horizontal-flow 
perfusions may be avoided. In horizontal-flow perfusions, there will always be 
absorption by the cells along the perfusion path, reducing the concentration 
levels based on the cells’ absorption rate of the components inside the perfusate 
(t half) as well as the contact time of perfusate to the cells (t) (left insert of Figure 
4.2). In order to minimize the affection of this gradient, the length of cell 
seeding chamber or channel is limited to scale up the cell number per data point, 
which can be desired for downstream assays. Whereas in a vertical flow 
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perfusion, the perfusate flow may be designed to reach and leave the cells 
across the culture area at the same time, which theoretically creates the same 
local environment for all the cells on the same plane. (right insert of Figure 4.2) 
This design is also useful when scale-up is a preference in the system. 
In horizontal and crossflow perfusions, there is also the mass transfer 
problems which needs to be addressed. The flow rate has to be carefully 
balanced to minimize shear stress and optimize mass transfer, which in turn 
means that not all the perfusate will come into contact with the cells. In contrast, 
the vertical flow pushes all the perfusate onto the cells, which guarantees the 
mass transfer. At the same time, the shear stress problem may be minimized by 
enlarging the cross-sectional area on the flow path so that the velocity (and 
therefore the impact as well as shear stress) near the cells may be lowered to a 
safe range for cells (see Analysis of problem1 in Section 4.5). 
Additionally, the integration of the microporous membrane filter in the 
vertical flow design may generate compaction, which has been found to benefit 
hepatic polarity and functions [15]. This compaction is also controllable and 
quantifiable by setting the proper pore size, density, thickness, diameter of the 
membrane as well as the flow rate of perfusion.  
 
 
                                               
ܥሺݐሻ = ܥሺ0ሻ 12ݐ/ݐℎ݈݂ܽ  
Figure 4.2 Horizontal versus vertical flow Left insert: horizontal flow brings an intrinsic gradient concentration when there is an absorption. Right insert: vertical flow makes the cells on the same plane encounter the same concentration. 
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Last but not least, the vertical flow design’s culture area is easily scaled up 
because the perfusion is no longer made on 2D surfaces like many microfluidic 
chips. All perfusion channels and tubings may be located above and below the 
culture chambers so that the foot print may be compact enough to accommodate 
multiple wells with large enough well sizes. For these reasons, a vertical flow 
design will enable the bioreactor to be modular and scalable. 
4.2.3 Key features of the Scalable Compaction Bioreactor Array 
(SCBA) 
In our setup, the scalable compaction bioreactor array (SCBA) is an open 
cap design so as to facilitate the easy harvesting of cells for downstream assays 
(Figure 4.3). The cap serves as the shear stress filter, and the bottom as the cell 
culture chamber. The main body of the SCBA was constructed with 
thermoplastic polymethyl methacrylate (PMMA). This is a good material for 
prototyping before production due to its biocompatibility, low cost, flexibility in 
Cell Culture Membrane
Shear Stress Filter Membrane
 Figure 4.3 Open-cap design and vertical flow path  
   60
fabrication for both machining, thermo-bonding and injection molding. The 
following issues will be addressed via the corresponding bioreactor components 
and features: 
 For the cap: 
1. Minimizing the shear stress: At a given flow rate, the expansion of the 
cross section area perpendicular to the flow direction will result in the decrease 
of velocity, lowering the shear stress at the exit. Additionally, the integration of 
a microporous membrane filter acts as a high flow resistance buffer, which 
lowers the impact of the perfusion flow onto the fragile cells after the filter.  
2. Even distribution of flow across the whole cross section area: As the 
diameter of the perfusion tubing is so small that when we expand the flow path 
to the diameter of the membrane filter, a flow distributor is needed to dissipate 
the flow evenly across the area of the membrane. If the flow resistance is evenly 
distributed throughout the membrane, the flow will be much faster at the center 
than at the sides (Figure 4.4b) when taking sampling points across the diameter 
(Figure 4.4a). It is therefore important to increase the flow resistance in the 
middle and adjust the distribution using a computational fluidic dynamic (CFD) 
simulation. 
3. Low buffer volume for in-time media replenishment: as the dead-end 
filtration receives 100% of the perfusate through the membrane, the flow rate is 
controlled at a much lower level as compared to the cross-flow type. For this 
reason, the volume before the cell substrate (the “buffer volume”) should be 
kept at a low level so that the media replenishment rate may be maintained, and 
cells may consistently be in contact with fresh media. However, as the cross-
section area needs to be large, the dimension of “height” (the distance between 
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the membrane filter and the cell seeding membrane below) should be kept at 
micron level in order to achieve a low buffer volume. 
 For the bottom: 
1. Sufficient cell number per data point: In prevalent microfluidic culture 
devices, cell numbers per data point are commonly limited by the micro-
chambers. The 3D-μFCCS developed by Toh et al could only accommodate 
several thousand hepatocytes [13]–[15], making it difficult to do downstream 
assays such as RNA extraction and immunofluorescence staining. Since the 
flow distributor expands the area at the filter, the cell seeding membrane below 
the filter should also be designed to be the same area so as to accommodate 
enough cells for each chamber. 
2. Controllable Compaction: In the report from Wang et al [15], the 
compaction generated by the pressure applied on the ceiling of an elastic 
microchannel may positively modulate the cells inside. However, in that paper, 
the compaction was done by manually controlled tweezers. In this paper, the 
perfusion flow regulated by the external pump generates the compaction force 
in a more controlled manner. When the flow resistance increases due to the 
integration of the microporous membrane at the outlet of the dead-end filter, the 
pressure builds up until it is high enough to drive the perfusate through the 
Figure 4.4 Velocity distribution across the perfusion area with equal flow resistance (A) Design of sampling points and channels along the diameter of the well. (B) Flow distribution shown by the length of flow in the sampling channels. 
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micro pores. This pressure acts as the compaction force onto the cells cultured 
inside the chamber, in an even and controllable way. 
3. Efficient mass delivery: There is no overlay of ECM on top of the cells 
cultured inside the compaction chamber. Due to the compaction mentioned 
earlier, this 2D cell culture setup produces results with a morphology usually 
observed only in 3D cultures and in vivo (See Session 5.3.6). Because of this, 
there is no possible adsorption by the ECM overlay during drug delivery. In 
order to supply enough O2 in the perfused media, a gas permeable tubing was 
used as an O2 generator before the perfusate reaches the bioreactor from the 
syringe pump.  
4. High Throughput: For drug testing purposes, a multi-well design is 
preferred for the purpose of increasing throughput. The bioreactor adopts a 24-
well culture plate footprint, dividing into 6 groups of 4-well units to cater to 
various scale requirements (Figure 4.3). 
5. Biocompatibility: All wet parts (parts which come into contact with 
culture media or cells) will be made out of biocompatible materials. The main 
body material, PMMA, has been reported to be compatible with a large range of 
cell types, including hepatocytes [142]–[144]. Each of the wells in the SCBA 
integrates a commercially available Transwell® Polyester (PET) membrane 
track-etched with 3 or 0.4 μm pores (Corning) as the shear stress filter in the 
flow distributor layer and another PET membrane with 0.4 μm pores as the cell 
seeding substrate. Notably, PMMA does not contact with hepatocytes directly in 
SCBA. The cells were seeded onto the microporous collagen-coated 
Transwell® membrane, which may be detachable freely from the SCBA for 
downstream assays. So the biocompatibility of SCBA mainly depends may be 
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verified via live-dead staining of hepatocytes cultured in static on the collagen-
coated membrane, which is shown in Figure 5.1B. 
With the abovementioned features, a scalable compaction bioreactor 
(SCBA) was fabricated and tested via perfusion culture of rat hepatocytes. 
4.2.4 Importance of hepatic functions for drug testing application 
Hepatocytes are the dominant cell type in the liver, and play a major role 
in the detoxification of the mammalian body. [36] In lieu of their 
biotransformation and toxin elimination functions, they have been widely 
cultured in vitro to serve in drug testing platforms [105], bioartificial support 
systems [137], therapeutic development models [37], etc. Specific for drug 
toxicology testing, as drug toxicity may be specific to species or organs, the 
compounds passed the animal test during pre-clinical trial may still fail on 
humans during or after clinical trials, which may lead to restriction of use or 
even market withdraw. [145] Therefore, it is important to develop in vitro 
culture model of hepatocytes so as to enable the drug testing on human cells.  
There are a number of parameters to evaluate the functions of hepatocytes 
during in vitro culture, of which the Albumin and urea production, level of 
Cytochrome P450 (CYPs) and polarities are important for drug testing purpose. 
Albumin is a protein specifically produced by hepatocytes [62] , and urea is a 
metabolite of functional hepatocytes. [64] These indexes can be easily checked 
on a daily basis from the used media, and indicate the basic functions of 
hepatocytes. Levels of CYPs are also important parameters indicating the 
metabolic function of hepatocytes to transform chemicals to another form. [64] 
Polarity re-establishment is also an important procedure for isolated hepatocytes 
to settle down on substrate, form colonies with neighbor cells and re-gain the 
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transporter activities, bringing out the cells’ toxins and metabolic.  [52] These 
parameters are especially important in drug toxicity testing, which predicts the 
toxicity levels of drug compounds when delivered to the liver. [67] 
4.3. Materials & methods 
4.3.1 Design of SCBA in different scales 
The SCBA was designed using Solidworks 2012 (Dassault Systèmes 
SolidWorks Corporation, USA) and AutoCAD (Autodesk, USA). There are 
typically two scales of the SCBA: a 2-well bioreactor and a 24-well array 
(Figure left top and bottom). The 2-well bioreactor was designed for 
optimization and small scale experiments, and the 24-well array is designed 
with large scale drug screening applications in mind. Both types of SCBA 
shares the same design of each individual well (Figure 4.5). The 2-well plate 
has two independent wells linked with perfusion tubings and valves fixed onto a 
jig. The 24 well array consists of 6 groups of 4-well units, where each unit 
shares the same perfusion tubings and valves which are controlled by a single 
syringe pump. The 24-well array utilizes the same footprint of a commercially 
available 24-well culture plate (Nunc®, Thermo) so that the bottom of the 
culture plate can simply be put under the SCBA as the collection plate for the 
perfusate. 
The main body of the SCBA is fabricated on PMMA plates. As shown in 
the right insert of Figure 4.5, there are 2 layers sandwiched with a membrane 
shear stress filter as the flow divider (cap) and another 2 layers directly bonded 
as the culture layer (bottom).  
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In the flow divider, the top layer consists of the flow enlarger interfacing 
the Φ1mm (ID) perfusion tubing with the Φ13mm opening, and the bottom 
layer consists of the flow distributor, which evenly distributes the flow velocity 
across the whole membrane. The entry orifice of the flow enlarger is linked 
with a slanted wall with 8 guiding grooves, which guides the flow along the 
wall and fills the whole shallow chamber. In between the flow enlarger and the 
flow distributor of each well, a PET membrane (Transwell® membrane track-
etched with 3 μm pores, Corning 3452) is sandwiched as the shear stress filter.  
In between the cap and bottom, there is a silicone O-ring for the water-
proof seal, and a PMMA ring clip (ID 13mm, OD 15mm, thickness 0.5mm) to 
fix a cell seeding membrane (Transwell® Polyester (PET) membrane track-
etched with 0.4 μm pores, Corning 3450) into each well (with 0.5mm concave). 
As the cell seeding membrane is track-etched with consistent pores at 
Flow Enlarger









Figure 4.5 A working prototype 2-well and 24-well SCBA Left-top: the 2-well SCBA conducting perfusion culture in a CO2 incubator. The two wells were independently perfused under control of a multi-well syringe pump. A jig connected with valves and tubing embraces the bioreactor and secured with screws. Left-bottom: the 24-well SCBA. Right: the insert shows the assembly of a unit well. Perfusion flows through the Flow Enlarger and Distributor to expand the cross-section area to whole well size. After supplying the perfusate to cells seeding on the Cell Seeding Membrane, the perfusate passes through the bottom flow distributor and Drain collector to be collected by the Eppendorf tubes for downstream assays. 
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micrometer level, the high resistance for the perfusion flow to sieve through the 
membrane may help to dissipate the flow to a more even and consistent pattern, 
and most importantly to generate compaction via increasing pressure near the 
cells. The pressure was estimated via CFD calculations as well as an ANSYS 
simulation, and the results are shown in Section 4.4.2. Notably, the O-ring, ring-
clip and cell seeding membrane may be taken out easily during cell harvest so 
as to facilitate the downstream assays like RT-PCR or imaging, which shows 
the benefit of the open cap design as stated in Section 4.2.3.  
In the culture layer, the top layer is a flow distributor, but with a 0.5mm 
depth concave in order to accommodate the ring clip and cell seeding membrane. 
(C) (D)
(A) (B)
Figure 4.6 Three designs of flow distributors. (A) Side view of the 3D model of flow distributors.  (B-D) Bottom view of the designs of flow distributors: (B) Design 1; (C) Design 2; (D) Design 3 
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This shallow well makes it easy to seed cells using a micropipette and also 
separate the cells from touching the surface above. The bottom layer is an up-
side-down flow enlarger, which serves as the drain collection facing the 
collection plate.  
The flow distributor contains an array of through holes with certain 
diameter distributions across the Φ13mm area. There were 3 types of the 
distributions tested in this project: 
Design 1. 20% increase by each concentric circle from centre to periphery.  
Design 2. Even distribution (control) 
Design 3. Even distribution but with the centre blocked by a cross 
In a nutshell, Design 1 and 3 adopts a high flow resistance in the center in 
order to dissipate the flow to the periphery of the chamber, whereas Design 2 
serves as a control with even distribution of flow resistance across the whole 
area. The dimensions of all three designs are shown in Figure 4.6 (B-D). This 
(A) (B)  Figure 4.7 Dissection of individual layers in SCBA main body (A) 2-well plate (B) 24 well plate 
   68
3D model (Figure 4.6A) was also used for simulation of flow velocity 
distribution in the CFD software ANSYS-CFX, and the results were shown in 
Section 4.4.2.  
As a summary, the 3D drawings of all the layers and parts in both 24-well 
and double well designs are shown in Figure 4.7.  
4.3.2 Fabrication of SCBA 
The 4 layers of the SCBA were firstly machined on 2mm thick PMMA 
plates according to the required scales and dimensions shown in Figure 4.7 
(Status, Singapore). The 3 µm pore-size PET membranes were then cut off from 
the scaffolds of Transwell® to serve as shear stress filters. The layers were then 
assembled via thermal bonding in the order of enlarger – shear stress - 
distributor and distributor – drain collector, which is shown in the right insert 
of Figure 4.5. All assembly work was done in a Class 1000 clean room in order 
to ensure bonding strength. 
As PMMA has been proven to be a biocompatible thermoplastic, thermo 
bonding was used to join the sections together. Thermo bonding does not 
involve any adhesives or tapes, thus lowering the risk of complications arising 
from introducing foreign materials, such as micro-feature blockage, surface 
property and biocompatibility change.[146] This is a reason why direct thermal 
bonding of PMMA is so widely used for microfluidic devices. [147]  
There were two methods of thermal bonding which were used for the 
assembly of the SCBA. The first method involves applying high pressure (as 
high as 200 psi) on PMMA via metal clamping plates and pressurized hotplates. 
(Figure 4.8A) The bonding surfaces are required to be plasma treated after 
wiping down with Isopropyl alcohol (IPA) and N2-blow drying. As the glass 
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transition point (Tg) for PMMA is 105°C [148], the temperature of the heating 
plate was adjusted from 93 to 96 ºC, and the bonding time was 20-40 min based 
on the observation and adjustment for the different batches of PMMA materials. 
The processing time was short, but there were limitations on the bonding area 
and evenness, and the use of high pressure in producing the SCBA meant that 
accurate temperature control was critical. Optimizations are needed for different 
batches, and the bonding effect is highly dependent on the operator’s skill. 
When under-bonding occurs, the parts may still be rescued by increasing the 
initial 15-min bonding time by 10-15 minutes at 1-2 ºC higher than the initial 
temperature set at 95 ºC. When over-bonding occurs, the collapse of micro-
features and the blocking of the shallow channels and chambers may largely 
change the flow resistance of the filters, causing the whole part unusable. The 
whole process involves a lot of estimations and trial-and-errors, and was heavily 
Room Temp
120 ºC, 1 hr
Ramping 1 hr




 Figure 4.8 Thermo-bonding of SCBA. (A) Thermo-bonding machine by hydraulic pressure. (B) Vacuum oven for surface dehydration. (C) High temperature oven for thermo-bonding. (D) Optimized bonding protocol in high temperature oven (E-F) The finishing surface of thermo-bonded SCBA with (E) and without(F) overnight vacuum oven dehydration. 
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dependent on manual operation and observation by bare eyes. This method is 
therefore only suitable for rapid prototyping. 
An improved method is to gently apply pressure (via paper clips onto non-
bonding clamping plates like thick glass) onto the PMMA layers and put the 
bonding parts into a high temperature oven to allow bonding at 120 ºC (Figure 
4.8C). A ready-to-use temperature protocol is shown in Figure 4.8D. As the 
bonding temperature is above the Tg of PMMA at 105 ºC, the flowing of the 
material at the interface makes the bonding strength strong enough to hold the 
sandwiched PET membrane, even though PMMA and PET do not bond with 
each other. Besides, the space of a high-temperature oven allows for a much 
bigger bonding area and higher throughput than the pressurized hotplates. The 
finishing products were perfectly transparent with no visible delamination or 
defects. (Figure 4.8E) Notably, the oven bonding requires the bonding surface 
to be vacuum dried at 80 ºC overnight (Figure 4.8B). Otherwise the evaporation 
of adsorbed moisture may result in an uneven finish, with bubbles trapped on 
the bonded surface (Figure 4.8F). This mode of production is ideal for small 
scale production when the design and fabrication protocols are confirmed. 
4.3.3 Hepatocyte isolation and maintenance 
Primary hepatocytes were isolated from male Wistar rats (250-300g). 
Cells were cultured in William’s E medium (Sigma, USA) supplemented with 1 
mg/mL bovine serum albumin (BSA) (PAA, Austria), 10 ng/mL epidermal 
growth factor, 0.5 mg/mL insulin, 5 nM dexamethasone, 50 ng/mL linoleic acid, 
10 units/mL penicillin, and 10 mg/mL streptomycin. Prior to seeding, the cell 
culture substrates were coated with 0.3 mg/mL acidic collagen (1:10 dilution of 
PureCol® collagen (Advanced Biomatrix, USA) in 0.1N hydrochloric acid), for 
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2-3 hours at 37°C, then washed three times with a 5-10 min interval in sterile 
phosphate buffer saline (PBS). The cells were then seeded onto the collagen-
coated membrane and maintained either in perfusion, static or collagen 
sandwich culture (as control) in an incubator with 5% CO2 and 95% humidity 
at 37°C. For the sandwich culture, an overlay of 0.3 mg/mL collagen was added 
onto the cells the following day. 
4.3.4 Prepare SCBA for Cell Seeding 
In order to connect the SCBA with perfusion tubings, a PMMA jig was 
machined with holes and threads through external vendor (Status, Singapore). 
Silicone O-rings were used to couple and seal the hard surfaces between SCBA 
and jigs. PEET tubings and four-way valves (Upchurch Scientific, USA) were 
used to deliver the perfusate from syringe to SCBA. Notably, there is a silicone 
air-permeable-water-proof tubing (Silastic® Laboratory tubing, 7-5224 
Cat#508-009) in the perfusion path, which serves as the O2/CO2 exchanger 
when the perfusion culture was done inside the CO2 incubator. The 
abovementioned parts were then prepared for the cell seeding procedures as 
shown in Figure 4.9.  
Sterilization: the tubings, valves and other PEET parts were autoclaved 
for sterilization at 105 ºC for 30 minutes and kept wet until usage. The purpose 
of using wet tubings is to lower the bubble generation in the flow path via pre-
wet surface. Other bioreactor parts made from PMMA and silicone (Figure 
4.9A) should be soaked in 70% ethanol overnight and then air dried on 
autoclaved tissue inside a UV-sterilized biosafety cabinet (BSC). This is to 
avoid the possible distortion of the thin plates or delamination of bonding 
because the autoclave temperature reaches the Tg of PMMA at 105 ºC. On the 
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day of cell seeding, the sterilized flow divider and culture layers were 
assembled in the jig inside the BSC. (Figure 4.9 C) 
Prime: the sterilized SCBA with flow path needs to be primed before 
seeding. Firstly, the whole flow path needed to be rinsed with continuous 
perfusion of Phosphate Buffer Saline (PBS) in the volume of at least 3mL/well. 
This is to remove leftover water or ethanol coming from the sterilization steps, 
which is hazardous to hepatocytes. [149] Then the PBS was replaced by 0.2% 
Bovine Serum Albumin (BSA)-PBS solution for 1mL/well and left in the flow 
path with valves closed for >1 hour. The reason for adding in BSA is to pre-coat 
a competitive protein so that protein adsorption may be lowered on the inner 
surface of the tubings. Immediate before cell seeding, the BSA-PBS solution 
was replaced with fresh William E medium for rat hepatocytes (Rat-Hep-WE) 
and then the SCBA was ready to accept the cell seeding membranes. 
Coating: the commercially available PET Transwell® membrane has been 













 Figure 4.9 Assembly of SCBA (2 well type) (A) The SCBA components: left column: jig to embrace SCBA; middle column: SCBA cap and bottom; right column: O-rings to seal jig-cap, O-rings to seal cap-bottom, ring clips, O-ring to seal bottom-jig. (B) Fix a cell seeding membrane with a ring clip. (C) SCBA embraced in jig with screw security. (D): Connect perfusion tubings to SCBA 
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following imaging, the track-etched 0.4 µm pore membrane (Corning 3450) was 
chosen as the cell seeding membranes. They were cut off from the plastic 
scaffold inside the BSC with sterilized blades. The diameter of the membrane 
was kept to be bigger than 16mm so as to leave enough space for fixing. They 
were then coated with collagen to facilitate cell attachment. Most of the 
experiments were done with the acidic collagen method (coated with 0.3mg/mL 
acidic collagen), which was selected from the optimization process. Some 
experiments were done with collagen gel method (coated with 1.5mg/mL 
collagen solution). The two types of coating protocols are explained below: 
 acidic collagen coating method 
1. Prepare 1:10 dilution of collagen gel stock in 0.1N HCl at room 
temperature to achieve 0.3mg/mL acidic collagen. 
2. Soak PET membrane in acidic collagen with a volume of 1mL/well in 
12 well plate. Make sure the whole cell seeding areas are immersed. 
3. Keep the 12 well plate in 37 ºC incubator for 2 to 3 hours. 
4. Wash 3 times with 5 min interval in 2mL/well PBS in order to remove 
acidic solution thoroughly. 
5. Replace PBS with 1mL/well Rat-Hep-WE and keep the membrane wet 
until prior to cell seeding. 
 collagen gel coating method 
1. Prepare solvent for collagen with: 3mL 0.1N NaOH (sterile), 3mL 10X 
PBS (sterile) and 18mL 1X PBS (sterile). Keep it sterile and cold in 4 ºC 
fridge or on ice. 
2. Add 24 mL collagen stock (sterile, concentration 2.9-3.1mg/mL) into the 
abovementioned COLD solvent and mix well with pipette to make 
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50mL collagen solution. NO filter step should be included after collagen 
is added. Keep it cold in 4 ºC fridge or on ice. 
3. Soak PET membrane in collagen solution with a volume of 1mL/well in 
12 well plate for 15 min at room temperature. 
4. Suck the collagen solution from the wells and keep the PET membranes 
at 37 ºC incubator for >1 hour. 
After priming and immediately before cell seeding, the coated membranes 
were fixed onto the cell culture chambers with ring clips inside BSC. (Figure 
4.9 B) 
Cell seeding: The rat hepatocyte suspension was kept on ice after isolation 
until seeding. The cells should be seeded as soon as possible within 5 hours 
after isolation. Prior seeding, the cell suspension was gently mixed via tilting 
the tube up and down slowly. Then the volume of 0.2 million cells was pipetted 
in each well. Some optimization experiments tested 0.4 million and 0.8 million 
cells/well (Section 5.3.1). A trick to make the cell suspension reside on the 
membrane evenly is to pipette the suspension in a spot-by-spot manner like a 
scanning over the whole cell seeding membrane. Then the cover and bottom of 
SCBA was enclosed in the jig and secured with screws. The whole SCBA set 
with tubings was finally sent for perfusion culture inside a CO2 incubator at 
37ºC and 5% CO2.  (Figure 4.9C) 
4.3.5 Hepatic function test  
The perfusate culture media were collected daily for each well of the 
bioreactor and kept at -20 ºC until hepatic function assay was carried out. The 
control was the supernatant of the static cultured hepatocytes on 24 well culture 
plate. Albumin production was quantified by enzyme linked immunosorbent 
   75
assay (ELISA) of rat albumin (Bethyl Laboratories, USA) and urea was by 
BUN urea nitrogen test (Stanbio Laboratory, USA). All functional data were 
normalized to seeded cell numbers, which were determined by PicoGreen assay 
(Molecular Probes, USA). 
4.3.6 Image processing and quantifications 
The polarity markers MRP2 (Aprical domain) and CD147 (basolateral) 
were counter-stained with DAPI (nucleus) immunofluorescent (IF) antibodies as 
stated in Section 5.2.4. The hepatocellular polarity was then quantified using 
MRP2/CD147 polarity index as in the algorithm illustrated in Figure 4.14. The 
Z-stack images of MRP2 and CD147 staining underwent 3D reconstruction, 
surface rendering and intensity summation using Imaris 7.7.1 (Bitplane, 
Switzerland).  
 
4.4. Results  
4.4.1 SCBA generates compaction in the culture chamber 
Due to the high flow resistance of the micro-pore Transwell® PET 
membranes, the pressure inside the cell culture chamber serves as a means 
to exert compaction forces on the cells. In order to confirm that this 
mechanical compaction inside the SCBA, the pressure on the cells caused 
by the perfusion flow was estimated via flow dynamics simulation. As the 
flow path opened to the atmosphere after the cell seeding membrane, the 
pressure on the cells may be easily estimated by calculating the pressure 
drop through the cell seeding membrane. So the model was built on the 
membrane pore. 
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As shown in Figure 4.10A, the total flow rate was set to 0.1 mL/hr. 
This flow has to pass through the Φ13mm cell seeding membrane 
(excluding the area occupied by the ring clip). According to the data sheet 
of the Transwell PET membrane, the nominal pore density is 4×106 pores 
per cm2. So there are 4×106×10-2mm-2×π×(13mm/2)2 mm2= 5.3068×106 
pores for the flow to pass through in the chamber. Then the average flow 
rate through each pore could be estimated as 0.1 mL/hr ÷ 5.3068×106 = 
1.88×10-8 mL/hr and the flow velocity through the Φ0.4µm pore may be 
calculated as 1.88×10-8 mL/hr ÷ π * (0.4×10-3mm/2)2= 15.0 mm/hr = 42 
µm/s. 
Then the pressure of the flow field near the cells may be estimated 
by calculating the pressure drop ( P ) of the fluid flowing through a 
membrane pore, which is modelled as in Figure 4.10B. According to the 




LfP D   
where, Df  is the Darcy friction factor; D is diameter of pores, 0.4 
µm; L is the length of pores or thickness of the membrane, 10 µm; and U 
is the average flow velocity in the pore. 
Based on the overall flow rate into each well (0.1 mL/hr, velocity 
optimization data in press), the pore size (0.4 µm) and pore density (4 106 
cm-2) on the membrane, the flow velocity near the cells is approximately 
42 µm/s, calculated using the formula: 
. Considering the possibility of 
membrane pore blockage when cells are seeded, the low to high blockage 
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ratio is estimated to be 10%, 60% and 90% according to images taken 
after harvesting. 
 (1) If 10% of the membrane pores are blocked by the cells, U = 4.63 















For laminar flow,  
 6104557.3Re











 UDLfP D   
Figure 4.10 Model of the cell chamber to estimate the pressure near the cells The total flow rate and chamber diameter (ID) was used to get the flow velocity through each pore of the cell seeding membrane (V). The insert at right shows the model of the single pore. As the SCBA is open end to the atmosphere, the pressure at the end of the pore is equal to atmosphere pressure. And the pressure near the cells may be estimated by adding on the pressure drop (ΔP) to the atmosphere pressure. 
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(2) If 60% of the membrane pores are blocked by the cells, U = 
1.042 10-4 m/s 
  (Pa) 4.208104.630 101.04261.92 -5
-4 P  
(3) If 90% of the membrane pores are blocked by the cells, U = 
4.168 10-4 m/s 
  (Pa) 5.833104.630 10168.461.92 -5
-4 P  
Similar values (e.g. 89.9 Pa at 10% and 177 Pa at 60% blockage, 
respectively) were obtained through numerical simulation using ANSYS-
CFX. In sum, the pressure experienced by the cells upstream of the 
membrane was estimated to be in the range of 0.09-0.8 kPa. Notably, 
833.5 Pa is equal to 6.25 mmHg. According to the data cited in Section 
2.2.1: “on top of the normal intra-abdominal pressure (IAP) at the range 
of 5-7 mmHg for human and 1.5-4.5 mmHg (2 to 6 cmH2O) for rats, the 
liver is subject to an additional pressure fluctuation of less than 
10mmHg”, the culture chamber pressure 833.5 Pa is within the range of a 
rat liver in vivo because it was reported under 1.5-4.5 +/- 10 mmHg 
pressure. 
Following that, the compaction pressure distribution in the flow field 
around a colony was then simulated, using 90% confluency as an example 
(Figure 4.11A). As the force generated by the flow field equals to the 
product of pressure and contact area, and considering that the force vector 
is perpendicular to the fluid-cell interface, the flow field pressurised the 
colony (depicted as blue arrows in Figure 4.11A) from both the top and 
side (Figure 4.11B upper insert), compacting and pushing the cells in the 
   79
colony together. In comparison, in the absence of any compaction forces, 
cells in static culture adopted a spread morphology (Figure 4.11B lower 
insert). 
Unlike the manual compression method employed in the previously 
developed 3D-µFCCS[15], compaction in the SCBA is tuneable, 
depending on the membrane pore size, density, flow rate, etc. 
Additionally, compaction can be easily applied to multiple wells 
 (A) 
        (B) Figure 4.11 Compaction at the scale of a hepatocyte colony (A) Simulation of flow field near the edge of a hepatocyte colony seeded on microporous membrane. 90% confluency was assumed so the pressure at the exit was set as 833.53 Pa, i.e. the calculated pressure at the entrance of membrane pore. Blue arrows depict the directions of compaction forces perpendicular to the membrane. (B) Hypothesized model of compaction on hepatocyte colonies due to vertical-flow perfusion through microporous membrane. Cells maintain cuboidal shape in compaction culture while they flatten in non-compacted static culture. 
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simultaneously. Therefore, the SCBA is a significant improvement and 
scale-up over the previously developed microfluidic-based compaction 
culture system [15] (where compaction can only be applied one 
microfluidic channel at a time) and therefore may facilitate the 
development of higher throughput drug testing platforms.  
4.4.2 Optimization of flow distributor design to achieve uniform 
compaction over a large culture area 
The SCBA was specifically designed to incorporate vertical flow, where 
the fluid flows perpendicularly to the plane of the shear stress filter as well as 
the cell-seeded membrane. As shown in the right insert of Figure 4.5, each unit 
in the SCBA starts with a 1 mm-diameter opening linked to a perfusion tubing. 
To enable the culture of a significant number of cells per data point, the SCBA 
was designed based on the use of 24-well plates with well diameter of 15 mm. 
The difference in size of the perfusion tubing (1 mm) and culture surface area 
(13mm) was addressed by the incorporation of a flow distributor, which serves 
to enlarge the cross-sectional area of the flow and minimize dead volume.  
As stated in Section 4.3.1, three types of flow distributor were tested via 
CFD simulation in order to optimize the uniform distribution of perfusion and 
compaction from a Φ1mm orifice entrance to a Φ13mm culture: 
Design 1. 20% increase by each concentric circle from centre to periphery.  
Design 2. Even distribution (control) 
Design 3. Even distribution but with centre blocked by a cross 
If the flow resistance on the cross section of the enlarged flow path were kept 
all the same, which is the case in Design 2, the flow velocity profile showed a 
parabolic shape, meaning the center of the cell seeding membrane may 
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experience a much faster perfusion than the periphery (Figure 4.4). The 
experimental phenomenon was in accordance with the simulation result that 
when the flow velocities of the sampling points along the radius were measured 
from center to periphery, the velocity curve exhibited a sharp decline as shown 
in the red curve in Figure 4.12B. A simple and natural way to conquer this 
unevenness is to block the center hole, as shown in Design 3. Here we used a 
cross shape as the blocker so as to guide the flow more dissipate to periphery. 
As shown in the blue curve in Figure 4.12B, the difference between the 
maximum and minimum velocity along the radius dropped by 30% in 
 Figure 4.12 Optimization of velocity distribution on 3 designs of flow distributor.  The top three diagrams are simulations of velocity at the cross section near the exit of the distributor. The hollow squares with numbers are the sampling points along the radius of the cross section. The velocity distribution curves are plotted in the lower graph. 
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comparison with Design 2. However, the flow still concentrated within 4mm 
from the centre, which was half of the radius. So there is still room for 
improvement. In Design 1, the diameter of the holes as well as distance between 
holes were designed to be increased from centre to periphery (Figure 4.6A), 
which made the flow resistance reduced along the radius. So when fluid flows 
out of the distributor, the higher flow resistance in the middle as compared to 
the periphery causes the fluid to flow towards the periphery of the culture area. 
The green curve in Figure 4.12B verified that the flow velocity distribution 
across the radius in Design 1 is much more uniform than the other two designs. 
4.4.3 Compaction was verified by morphological change of 
hepatocytes 
The effects of compaction were verified through an analysis of cell morphology 
as shown in Figure 4.13. 4 hr after seeding, hepatocytes on standard tissue 
culture plastic had begun to attach to the surface with loose cell-cell contacts 
while the cells statically cultured on the Transwell® membrane were still round 
with minimal cell attachment to the underlying membrane. In contrast, under 
compaction, cells on the same membrane formed compact colonies (Figure 
4.13A, Row 1). With time in culture at day 1 and 3, hepatocytes under static 
culture on either standard tissue culture plastic or on the membrane adopted a 
spread morphology whereas those under compaction culture maintained their 
tight, compact morphology (Figure 4.13A, Row 2 & 3). Quantification of the 
cell shape descriptor, aspect ratio, showed that hepatocytes under compaction 
were able to maintain a cuboidal shape, while cells in static cultures adopted 
significantly more elongated and random shape (Figure 4.13B-C). 3D 
reconstruction of actin and 2D projection to the Z plane also indicates that 
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compaction in the SCBA resulted in hepatocytes adopting a standing cuboidal 
cell shape while cells in static and sandwich culture were flattened (Figure 
4.13D). In sum, the abovementioned data demonstrates that compaction 
generated by vertical-flow perfusion through a microporous membrane results 
in hepatocytes forming tighter colonies and maintaining a cuboidal shape as 
early as 4 h after seeding. 
4.4.4 Hepatic functions were enhanced to facilitate drug testing 
applications 
For drug testing applications, it is preferable to maintain cell functions in 
the long term culture so that the chronic effect of drugs could be tested. The 
compaction present in the SCBA were shown to keep the hepatocytes’ 
morphology throughout the 14-day culture (Figure 5.1A). Both urea and CYPs 
  Figure 4.13 The effect of compaction on cell morphology (A) Morphology of hepatocytes under compaction and non-compaction (static culture on membrane (memb), tissue culture plate (TCP) and collagen sandwich) after 4 hours, 1 day and 3 days under 10X PH microscope. (B-C) Quantification of cell aspect ratio using ImageJ. Images taken at Day 3. Asterisks indicate statistical signiﬁcance compared to compaction culture; Student’s t-test, * p < 0.001. (D) 3D reconstruction of actin (green) counter-stained with DAPI (blue) of hepatocytes cultured for 3 days (upper row) and 2D projection of the cells to Z plane (lower row). Scale bar = 5 microns. 
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production were quantified as shown in Figure 4.14. For urea production, the 
perfusion culture maintained at 8 to 20 folds higher than the static culture 
throughout the whole 2-week culture (Figure 4.14A). For the CYP1A2, 2B2 and 
3A2 results of the cells harvested at the end of 2-week culture, the perfusion 
cultures all exhibited higher production levels than the static control as well 
(Figure 4.14B-D). All results show that the SCBA may indeed be a promising 
drug testing platform for long term cultures. 
4.4.5 Polarity Index to quantify the process of polarity acceleration  
IF staining of apical domain marker MPR2 against the basolateral domain 
marker CD147 shows that MPR2 started to concentrate on cell peripheries upon 
4 hours of perfusion in SCBA, while the two markers in the non-compact 
monolayer control were still diffusive in the cytosol, which is a sign of non-
polarized cells (Figure 5.5A). As culture time increases, the two markers 
Figure 4.14 Hepatic function assays targeting drug testing application (A) Urea production over 2 weeks (Unit: mg/million cells/day). Normalized to seeded cell number.  (B-D) Basic Cyp level tested via LC-MC. Cells were harvested after 14-day culture: (B) CYP1A2 (C) CYP2B2 (D) CYP3A2.  
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displayed a greater extent of separation in perfusion than static culture. This 
improvement of polarization level may be quantified using Polarity Index (PI). 
This index is obtained through the method shown in Figure 4.15A and the 
principles are elaborated as below: 
In polarized cells, MPR2 and CD147 should be exclusive to each other. 
Hence the IF intensity ratio of MPR2 over CD147 (MRP2/CD147) should be 
high in MPR2 dominant regions but low in CD147 dominant ones. The Polarity 
Index was calculated accordingly via dividing the MRP2/CD147 value in the 
MRP2 dominant regions by the value in the CD147 dominant regions, meaning 
the higher the index, the higher the polarity level. Notably, the separation level 
of MRP2 and CD147 may also be quantified via “colocalization percentage”, 
which is a widely accepted parameter (Section 5.3.5). However, this percentage 
is negatively correlated with the polarity level, which means the lower the 
percentage, the higher the polarity. It is thus beneficial to explore the new index 
PI in this paper in order to obtain a more straightforward index for polarity 
quantification. 
As shown in Figure 4.15B, the cells cultured in SCBA showed 
significantly higher PI than static control 4 hours after perfusion. The polarity 
Figure 4.15 Quantification of polarity level via Polarity Index (PI). (A) Algorism to calculate PI using Imaris surface rendering and statistics. (B) PI for static and perfusion cultured cells to quantify the polarity re-establishment process for a 3-day period. The level of rat liver tissue was used as the benchmark. Error bars show the standard error of the mean (SEM, n=3-9). Asterisks indicate statistical signiﬁcance compared to the perfusion culture; Student’s t-test, ** p < 0.1 and * p < 0.05. 
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level in SCBA kept increasing with time and reached a level lower than but not 
far away from the liver tissue at Day 3 (Figure 4.15B, p value<0.1). The 
perfusion culture showed an enhanced polarity as compared to the static culture 
throughout the experiment, which is in concurrence with the findings in 3D-
mFCCS. Notably, the results and trend over time of PI also follows the ones in 
the colocalization percentage, (Figure 5.5B) when the same set of IF staining 
data were analyzed. So the validity of PI is supported from an additional angle.  
4.5. Discussion 
The SCBA adopts a novel vertical-flow design, which means the perfusion 
flows perpendicularly to the plane of the shear stress filter as well as the cell 
seeding substrate membrane. As stated in Section 4.2.2, there are many 
advantages in adopting vertical flow design, such as guaranteed mass transfer, 
minimized concentration gradient, possibility to generate controllable 
compaction, convenience to scale up culture area and throughput, etc. However, 
to our knowledge, there are no vertical-flow design bioreactors being used for 
cell culture in the market so far. Why is that the case? The possible reasons are 
analyzed below: 
1. Risk of cell damage caused by impact of vertical flow. 
In the microfluidic scene, the cross sections of perfusion channels are 
generally kept at micron-levels, which makes the velocity along the channel 
high enough to damage the cells even when the flow direction is parallel to the 
cell culture surface. The input flow rate is thus commonly kept near to the 
minimum end of syringe pumps, and careful optimization work was crucial to 
maintaining cell viability [13], [14]. Therefore, applying perfusion directly onto 
the cells from above has never been an option. 
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However, we have scaled up the culture area and put it perpendicular to 
the perfusion direction. This change of cross-section area of flow path enables 
the flow velocity onto the cells to be kept at a cell-friendly level while keeping 
the flow rate manageable by syringe pumps. As we all know, the impact of a 
moving object is determined by mass times velocity. At a given mass transfer 
rate, the impact of perfusion is mainly decided by the flow velocity reaching the 
cells. As shown in Figure 4.10, the flow velocity near the cells in SCBA is as 
small as 0.15 m/hr or 42 µm/s when the flow rate is 0.1mL/hr per well. This 
value is close to the normal spermatozoal velocity during fertilization in human 
body. [151] This velocity could be brought down even lower by changing the 
pore size and/or density on the membranes, given that a milder perfusion is 
needed. Therefore, cell damage can manageably be kept at a minimum range 
when the flow path is designed in the concept of SCBA.  
2. Worry of cell damage caused by pressure. 
In most people’s impression, cells (especially hepatocytes) are ultra-
fragile, and do not like to undergo mechanical forces such as shear and pressure. 
However, there are a few papers stating that an optimum amount of shear may 
enhance hepatic functions; [152], [153] there is even a paper from our 
laboratory proving for the first time that the pressure generated by manual 
compaction on the chamber ceiling above the cells may aid hepatic function 
recovery during in vitro culture. [15]  
The pressure applied to the cells in the SCBA is hydrodynamic pressure, 
generated by the high flow resistance of the porous membrane. The pressure 
build-up inside the culture chamber effectively functions as compaction for the 
cells. Unlike the manual compression method, this compaction is much easier to 
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regulate, and may be scaled up to multiple wells, which provides the element of 
convenience in drug testing applications. 
3. Over-stress on miniaturization on all three dimensions. 
Microfluidic devices have many advantages such as low volume per 
reaction, fast turn-over time, high throughput, cost-saving, etc. [6], [154]–[158] 
Much effort has been made in miniaturizing conventional reactions onto 
microfluidic chips. However, in terms of practical application, not all users 
share the same “smaller is better” sentiment. In the example of perfusion culture 
system for drug testing, the 3D-µFCCS may accommodate 3 to 5 thousand cells 
per channel, which made it difficult to carry out some downstream assays such 
as RNA extraction. [15]  
In order to culture significant numbers of cells per data point, the SCBA 
offers a Φ13mm culture area (out of the 15mm well diameter) in each well to 
accommodate 0.2-0.4 million cells per well. The height of the cell culture 
chamber, however, is still kept at 500 µm so that the whole volume of the 
chamber is only 88 µL. There is thus no need to over-stress on miniaturization 
at all three dimensions. Even when enlarging the cross-section area to 
millimeter level, we may still achieve the benefits of “microfluidics” while 
bringing in additional advantages like low local velocity (hence low shear stress) 
and adequate cell number per data point.  
 
4.6. Conclusion 
In summary, the SCBA has adopted a novel vertical flow design to scale 
up a previously reported microfluidic perfusion device into a multi-well array 
with uniform, quantifiable and controllable compaction on cells. Optimizations 
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of bioreactor design as well as cell seeding conditions has been done to ensure a 
working prototype. Hepatic function assays supported the hypothesis that the 
SCBA may enhance hepatocyte functions in long term cultures, and the 
quantification of polarity also showed accelerated polarity recovery. The SCBA 
is thus a promising modular and scalable drug testing platform with adequate 
cell numbers per test, high throughput and improved cell functions. 
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Chapter 5. Scalable Compaction Bioreactor 
Array Enhances Hepatic Polarity and Functions 
The extent of intercellular contact and adhesion between cultured 
hepatocytes is a critical parameter that influences the differentiated phenotype. 
Using a microfluidic device, the application of external mechanical forces to 
artificially compact cells and forge cell-cell interactions was previously 
demonstrated to be effective in accelerating hepatic repolarization. In seeking to 
implement this approach to higher throughput culture platforms for drug 
screening applications, we specifically designed the scalable compaction 
bioreactor array (SCBA) that is compatible with hepatocytes simply cultured as 
monolayers on standard multi-well plates. As a result of vertical perfusion-
generated forces, hepatocytes were observed to undergo compaction in this 
bioreactor and not only exhibited accelerated repolarization, an in vivo-like 
cuboidal morphology, but also better maintained hepatic functions in long-term 
culture as compared to the same cells cultured under static conditions. As a 
novel engineering tool to modulate cell compaction and intercellular 
interactions, this SCBA platform is a promising approach to confer tight control 
over hepatocyte repolarization for in vitro culture. 
5.1 Introduction 
In seeking to maintain liver-specific functions of cultured hepatocytes in 
vitro, various reports have clarified the importance of extracellular matrix 
(ECM) components and hormones in promoting the differentiated phenotype 
[49], [159]. Beyond cell-matrix interactions and biochemical cues, cell shape 
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(and associatively, cell-cell interactions) has also been shown to be a critical 
parameter that influences the hepatic phenotype. Hepatocytes cultured at high 
density as monolayers adopt a more compact morphology with extensive cell-
cell contacts and better maintain the differentiated hepatic phenotype as 
compared to the same cells cultured at low density[160]. Like-wise, modulation 
of the ECM geometry, as in the case of the collagen sandwich model, has been 
shown to promote the in vivo-like polygonal hepatocyte morphology, formation 
of gap junctions, bile canaliculi networks and maintenance of hepatic functions 
[161]–[163]. In the absence of any overlay, hepatocytes rapidly flatten and 
dedifferentiate.  
Given the importance of cell-cell adhesion in establishing hepatocyte 
polarity [164], we previously reported the development of a microfluidic system 
as a means to investigate the role of homeostatic pressure, as effected by the 
application of external mechanical compaction, on hepatocyte polarity [15]. 
Homeostatic pressure was recently proposed as one of the mechanisms that 
regulates the strength of intercellular adhesions [31]. By seeding hepatocytes at 
high density between micropillars in a microfluidic channel and applying 
mechanical peristaltic forces, cells were rapidly compacted together, adopted an 
in vivo-like cuboidal morphology and an increase in intercellular contact area 
was observed [15]. This increase in intercellular contact area and adhesion 
resulted in the accelerated bile canaliculi formation [15]. 
 That the application of external mechanical compaction can effectively 
improve the functional phenotype of cultured hepatocytes via the rapid 
establishment of intercellular contact and adhesion led to the current study, 
where we sought to scale-up and increase the throughput of the previously 
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developed microfluidic system[15] for drug screening applications. In seeking 
to design and engineer such a higher throughput culture system, we asked if 
external mechanical compaction forces applied to hepatocytes cultured in 
standard multi-well plates as monolayers would similarly foster intercellular 
contact and adhesion. Of note, hepatocytes cultured as monolayers typically 
exhibit a flattened morphology, remain non-polarized and rapidly lose their 
hepatocellular functions [53]. We hypothesized that the provision of pressure, as 
effected by perpendicular perfusion flow, to hepatocyte monolayers would 
mechanically compact cells, hence resulting in the recapitulation of in vivo-like 
cell morphology, cell-cell interactions and hepatic functions. 
To this end, we developed the multi-well scalable compaction bioreactor 
array (SCBA) which, to our knowledge, is the first vertical-flow bioreactor 
reported. In this bioreactor, controlled compaction is applied by employing the 
use of a micro-pore membrane that not only serves as a shear stress filter, but 
also as a barrier that provides resistance against the perpendicular perfusate 
flow. Such a set-up enables the application of pressure and minimizes the 
formation of concentration gradients in typical cross-flow designs. Despite 
being grown as monolayers, hepatocytes grown in SCBA adopted a 3D 
morphology, exhibited accelerated repolarization and in vivo-like actin 
organization, and maintained hepatic functions in long-term culture. 
5.2 Method and materials 
5.2.1 Perfusion culture of hepatocytes in the SCBA 
The SCBA was sterilized by soaking it in 70% (v/v) ethanol overnight. 
The perfusion tubing and valves were sterilized by autoclaving at 90 °C. Parts 
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of the SCBA subject to fluid flow were assembled in a biosafety cabinet, 
flushed with PBS then primed with 0.2% (w/v) BSA (PAA, Austria) dissolved 
in PBS. Immediately before seeding, the BSA solution was replaced with 
complete medium. Then primary hepatocytes were seeded onto collagen-coated 
substrate. The SCBA was subsequently assembled and perfusion was started 
immediately. The entire set-up was then kept in an incubator with 5% CO2 and 
95% humidity at 37°C. The perfusion rate was controlled by a multi-channel 
syringe pump (Cole-Parmer, USA). 
5.2.2 Morphological observation and live-dead staining 
Phase contrast (PH) images of hepatocytes under perfusion were taken 
following the removal of the cell-seeded membrane from the SCBA into warm 
culture medium. Cells grown in static culture were maintained in the culture 
plates and similarly imaged. 
Live-dead staining was performed using Calcium AM (5 μM, Invitrogen, 
USA) as an indicator of live cells and Propidium Iodide (PI, 50 μg/mL, 
Molecular Probes, USA) as an indicator of non-viable cells. Following the 
addition of the reagents, the cells were incubated for 5 min, washed then imaged 
immediately using a confocal microscope (Olympus IX71). 
5.2.3 Hepatic function assays 
Culture medium was collected daily from the outlet of each well in the 
SCBA as well as from the static cultures. Albumin production was determined 
using a “rat albumin enzyme linked immunosorbent assay (ELISA)” kit (Bethyl 
Laboratories, USA) while urea production was quantified using a “BUN urea 
nitrogen test” (Stanbio Laboratory, USA). Values obtained were then 
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normalized to the number of seeded cells, determined by PicoGreen assay to 
measure DNA content (Molecular Probes, USA). 
CYPs expression level was quantified by Quantitative PCR (qPCR) of 
reverse transcribed genes CYP1A2, CYP2B2 and CYP3A2. Cells in the SCBA 
were firstly lysed by soaking the cell seeding substrate in the RLT buffer from 
the RNeasy® Micro kit (QIAGEN, Germany). Total RNA was then isolated 
from the cell lysate according to manufacturer’s protocol. RNA transcription to 
cDNA was done by All-in-One first-strand cDNA synthesis kit (GeneCopoeia, 
USA) according to manufacturer’s protocol. qPCR was performed using a 
customized All-in-OneTM qPCR Primer Array (GeneCopoeia, USA) in the All-
in-OneTM qPCR Mix (GeneCopoeia, USA) and performed on the ABI 7500 
Fast Real-Time PCR system (Applied Biosystems, Life Technologies, USA). 
Transcript levels were normalized to the housekeeping gene GAPDH. 
5.2.4 Immunofluorescence staining of F-actin and polarity markers 
Cells were incubated in 4% paraformaldehyde for 30 min at 37°C 
then permeabilized with 0.1% Triton X-100/PBS (Biopolis Shared 
Facilities, Singapore) for 30 min at room temperature (RT). Then, cells 
were blocked with 0.1% BSA in permeabilization buffer for 4 h at 4°C 
and conjugated with primary antibody overnight at 4°C. Following the 
primary antibody incubation, cells were washed five times in blocking 
solution at 15 min-intervals under 50 rpm orbital shaking at RT (washing 
step). The secondary antibody and Phalloidin (1:200 dilution, Alexa Fluor 
488, Invitrogen, Life Technologies, USA) was then added and cells were 
further incubated at RT for 1 h. Following another wash with PBS, DAPI 
(1:10000) was added as a counter-stain for 15 min. Cells were then rinsed 
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with PBS, mounted with mounting media (Dako, Denmark) and dried at 
RT before they were imaged. The working primary antibody 
concentrations were 1:200 for rabbit anti-MRP2 (M8316, Sigma, USA) 
and 1:20 for mouse anti-CD147 (AbD SeroTec, UK). The secondary 
antibodies used were at 1:200 for Alexa Fluor 555 Donkey Anti-Rabbit 
IgG (H + L) (A31572, Invitrogen, USA) and Alexa Fluor 647 Donkey 
Anti-Mouse IgG (H + L) (A31571, Invitrogen, USA). The imaging was 
performed using confocal microscopy (Nikon A1R, Japan). Negative 
controls were prepared by excluding primary antibodies. 
5.2.5 Fluorescein Diacetate (FDA) staining on live cells 
FDA dye (F7378, Sigma, USA) was first diluted in culture medium 
(pre-warmed to 37°C) to a final concentration of 15 μg/mL, and then 
pipetted into the well plates. Cells were incubated with the dye for 30 min 
at 37°C, and then washed once with warmed culture medium. A coverslip 
was placed on the cells to minimize contact with air and confocal images 
were taken immediately. 
5.2.6 In vivo and ex vivo imaging on actin cytoskeleton in liver 
tissue 
Hepatocyte morphology and actin organization in the SCBA was 
validated by comparison to that in vivo, employing the liver window 
model of transgenic Lifeact–EGFP mice. [165], [166] The mice were a 
general gift from Dr Roland Wedlich-Söldner and were handled under 
IACUC approval. In brief, the filamentous actin (F-actin) of the 
transgenic mouse was labelled with Lifeact–EGFP to enable the 
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visualization of the actin cytoskeleton in liver cells; an abdominal imaging 
window was used to expose the liver for intravital imaging of liver 
surface. An in-house built two-photon-microscope was used to take the 
images of actin cytoskeleton of liver cells and quantification was 
performed as described in Section 5.2.7. Recognizing that there may exist 
subtle differences in hepatocyte morphology and actin distribution in rat 
versus mouse, we compared the morphology and actin distribution of 
hepatocytes in the in vivo mouse model to that of ex vivo rat liver tissue. 
The rat liver was dissected from male Wistar rats (250-300g) and then 
was sliced into 0.5 mm-thick sections immediately following resection 
and then fixed in 4% PFA for 30 min at 37 °C. IF staining was then 
performed as described in Section 5.2.4 and images were taken using a 
confocal microscope (Nikon A1R, Japan). The images were processed and 
quantified as described in Section 5.2.7. Figure 5.7 indicates that the 
hepatocyte morphology and actin distribution in the in vivo mouse model 
is similar to that in the ex vivo rat liver tissue. 
5.2.7 Image processing and quantifications 
Hepatocyte polarity was quantified using the MRP2/CD147 co-
localization percentage via the Imaris 7.7.1 (Bitplane, Switzerland). Z-
stack images of MRP2 and CD147 staining were obtained for 3D 
reconstruction, surface rendering and intensity summation, using the 
Imaris software.  
The spread width of actin fibres was measured using Fiji as 
previously described [167]. Straight lines were manually drawn across 
cortical actin in the top, middle and bottom planes, and the widths of the 
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intensity curve that lie above the pre-set threshold were measured. For 
each cell, 2-4 random measurements were made; a total of 100-200 
measurements were made for both static and perfusion cultures. The 
distribution was then plotted using Origin 8.5.1 (OriginLab, USA). 
 
5.3 Results and discussion 
5.3.1 Compaction does not attenuate the cell viability 
Unlike hepatocytes in static culture which flatten and spread on the 
underlying collagen-coated membrane as expected, we observed that the 
same cells cultured in SCBA adopted a cuboidal, three-dimensional shape 
with distinct cell-cell boundaries (Figure 4.13 and Figure 5.1A). Notably, 
this hepatocyte-specific morphology was maintained for 14 days in the 
absence of any matrix overlay (Figure 5.1A). Furthermore, using stains 
for viable and dead cells, we established that perfusion culture and 
Figure 5.1 Cell morphology and viability in the bioreactor  (A) Cells maintain distinct cell-cell boundaries through 14 days of perfusion culture while few cells remained in static culture. PH images all taken under 10X phase contrast optical microscope. (B) Live-dead staining demonstrating viability of cells in the SCBA under perfusion and static culture. 
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compaction in the SCBA did not negatively affect hepatocyte viability 
(Figure 5.1B). 
 
5.3.2 Optimization of cell seeding density 
The standard cell seeding density in our lab was 0.2 million cells/well in a 
24-well plate (>1×105 cells/cm2), which gave rise to 80-90% cell confluency 
(Figure 5.2A & D). Higher cell seeding density was also tried in the SCBA (0.4 
and 0.8 million cells / well). However, as shown in Figure 5.2B & E, there is no 
significant increase in the confluency when seeding density doubles to 0.4 
million/well. And if the density was increased too high (Figure 5.2C), lots of 
dead cells will attach to the colonies and block the observation. 
Moreover, urea production, as an important hepatic function indicator was 
used here to optimize the cell seeding density. It may be conveniently quantified 
by running assays in the used media, which may be sampled on a daily basis 
without affecting the culture process. [64], [65]. The hepatocytes cultured in the 
(A) (B) (C)
(D) (E) (F)  Figure 5.2 Optimization of cell seeding density via urea production (A-C) Cells seeding with different densities in compaction culture: (A) 0.2million/well, (B) 0.4million/well, (C) 0.8million/well (D-E) Static control: (D) 0.2million/well, (E) 0.4 million/well. PH images all taken under 10X phase contrast optical microscope. (F) Urea production was tested for 4 days for different seeding densities. All results normalized to seeded cell numbers. Error bars show the standard error of the mean (SEM, n=2-4). 
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SCBA were then compared with the static control, which were seeded on the 
same type of PET membrane in a monolayer and cultured in a 24 well culture 
plate. As shown in Figure 5.2F, all perfusion cultured hepatocytes produced 
significantly higher urea than static cultured ones. Among the 3 seeding density, 
the 0.2 million cells per well cell density showed the highest urea level. This 
density is the same as the prevailing density seeded for the 24 well plate. 
Therefore, the seeding density of 0.2 million cells per well was regarded as the 
optimized condition and was used for following assays. 
5.3.3 Optimization of perfusion flow rate 
To optimize the effect of mechanical compaction in the SCBA on 
the cultured hepatocytes, we adjusted the perfusion flow rate and used 
levels of albumin and urea production as indicators of hepatic functions. 
Hepatocytes cultured in the SCBA were compared with the static culture 
control, where cells were seeded on the same membrane and cultured in a 
24-well plate in the absence of perfusion. In static culture, culture medium 
of 0.5 to 0.6 mL was replaced daily. If the same amount of medium were 
to be considered for perfusion culture, the corresponding flow rate for 
each well would be 0.02 to 0.03mL/hr. Therefore, we tested the following 
three flow rates: 0.0011 mL/hr, 0.036mL/hr and 0.1 mL/hr. The 
morphology of hepatocytes after 3 days of perfusion or static culture is 
shown in Figure 5.3A. It is shown that all cells under compaction obtain 
clear cell boundaries. But only the cells under perfusion of 0.1mL/hr and 
0.036mL/hr exhibit a typical cuboidal shape whereas those under 
0.011mL/hr presents a more irregular shape. Therefore, the flow rate 
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0.011mL/hr may not be an optimal condition to maintain a hepatic 
morphology of cells. 
After normalization against the number of seeded cells, albumin 
production under 0.1mL/hr of perfusion was shown to significantly 
outperform other perfusion conditions (Figure 5.3B). Additionally, 
perfusion-cultured hepatocytes produced significantly greater amounts of 
urea as compared to statically cultured cells. Specifically, cells cultured 
under 0.1mL/hr of perfusion secreted the greatest amount of urea, 
Figure 5.3 Optimization of perfusion flow rate. (a) Morphology of rat hepatocytes after perfusion for 3 days in different flow rate in comparison with static culture control. PH images all taken under 10X phase contrast optical microscope (b) Albumin production for 3 days. Data normalized to seeded cell number. (c) Urea production for 3 days. Data normalized to seeded cell number. Error bars show the standard error of the mean (SEM, n=4). Asterisks indicate statistical signiﬁcance compared to the optimal perfusion condition (0.1mL/hr); Student’s t-test, ** p < 0.1 and * p < 0.05. 
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consistently producing approximately 10-folds greater as compared to 
those in static culture (Figure 5.3C). These results corroborate with 
previous studies[15], where we found that mechanical compaction results 
in maintenance and enhancement of hepatic functions Notably, as the flow 
rate 0.1mL/hr flushes each well with 2.4mL media per day, the 
metabolites for downstream assays are already diluted in 4 to 5 folds in 
the media than static culture (0.5-0.6mL/well). So 0.1mL/hr is considered 
at the high end of flow rate and no further test of higher flow rate was 
conducted. Therefore, 0.1mL/hr was taken as the optimized condition and 
all the calculations and assays were done at this flow rate. 
5.3.4 Perfusion and mechanical compaction in SCBA maintains 
hepatic functions in long term culture 
To investigate the effect of mechanical compaction in the SCBA on 
hepatic functions, we probed for albumin production and urea secretion 
over a period of 14 days. Overall, we found that albumin levels in 
hepatocytes cultured in the SCBA were similar to cells grown under static 
conditions, although not as high as compared to the same cells grown in 
the collagen sandwich culture (Figure 5.4A). Urea secretion was 
consistently 10-20 folds higher as compared to static culture and 6-10 
folds higher than the collagen sandwich culture over the 14-day culture 
term (Figure 5.4B). 
As CYP levels is an important parameter that determines the utility 
of this model for drug testing applications, gene expression of CYPs were 
measured after 14 days of culture. As shown in Figure 5.4C, levels of 
Cyp1A2 and Cyp2B2 in hepatocytes under perfusion in the SCBA were 
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significantly higher than the static and sandwich culture. And even though 
sandwich culture outperformed in Cyp3A2, the perfusion and static 
culture were still at similar level. In sum, these findings indicate that the 
SCBA supports long-term perfusion culture of hepatocytes without 
attenuation of hepatic functions, similar to our previous findings based on 
the microfluidic-based compaction culture system[15]. 
 
5.3.5 Culture in SCBA enhances hepatocyte polarity 
A key determinant of transporter activity, particularly important in 
drug testing, is hepatocyte polarity[53]. One of the major findings in the 
previously developed microfluidic model was that mechanical compaction 
accelerates bile canaliculi formation[15]. Hence, we validated the SCBA 
Figure 5.4 Hepatic function in long term culture (A) Albumin and (B) Urea production for 2 weeks. Data normalized to seeded cell number. Error bars in (A) and (B) are the standard error of the mean (SEM, n=5-8). (C) Relative mRNA levels (to Gapdh) of CYP genes at Day 14. Error bars in (C) are the standard error of the mean (SEM, n=3-5). Asterisks indicate statistical signiﬁcance compared to perfusion culture (0.1mL/hr); Student’s t-test, ** p < 0.1 and * p < 0.05. 
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by assessing the degree of polarity re-establishment, staining for apical 
domain marker MRP2 and basolateral domain marker CD147. 
Additionally, we also used FDA excretion into bile canaliculi as a 
measure of hepatocyte excretory function[69].  
Following 4h of perfusion in SCBA, MRP2 expression was found 
mainly at the cell periphery. In contrast, both MRP2 and CD147 in the 
static control were largely located in the cytoplasm, indicative of non-
polarized cells. Over time, spatial segregation of the two polarity markers 
was more distinct in perfusion culture as compared to the static control 
(Figure 5.5A). The degree of polarization was quantified using the co-
localization function in the Coloc module of Imaris. The percentage of 
MRP2 and CD147 co-localization should be low in polarized cells given 
that they are apical and basolateral markers, respectively. As shown in 
Figure 5.5B, the co-localization percentage in hepatocytes cultured under 
perfusion was significantly lower as compared to those in static culture, 
indicating that cells were more polarized in SCBA. Notably, consistent 
with our previous findings[15], culture in the SCBA accelerated the re-
establishment of polarity to 12 hr following the initiation of perfusion. 
Additionally, the degree of polarity level in perfusion culture reached the 
level of that in vivo at 12 hr but similar re-establishment took 3 days for 
static culture. 
To further confirm the polarity in live cells, we used FDA 
(fluorescent substrate of the MRP2 transporter) staining to probe the 
excretory function of MRP2[69]. Through live-imaging, we found that 
FDA was secreted into bile canaliculi in the collagen sandwich culture, 
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but remained diffuse in the cytoplasm for the static control. FDA secretion 
for cells cultured in the SCBA was found in both compartments (Figure 
5.5C), suggesting that further optimization of the SCBA is necessary to 
improve hepatocyte excretory function. 
 
5.3.6 Cortical actin distribution of hepatocytes in SCBA is close to 
in vivo situation 
 Figure 5.5 Staining of polarity markers (A) Immunofluorescence staining of MRP2 (red) and CD147 (white) with DAPI (blue) depicting nucleus. (B) Quantification of MRP2/CD147 colocalization percentage. N=4-9 from 3 independent experiments. (C) FDA staining of live hepatocytes at Day 3. Left column: FDA (green); Middle column: T-PMT bright field; Right column: merged. Asterisks indicate statistical signiﬁcance compared to compaction culture (Q=0.1mL/hr); Student’s t-test, * p < 0.05. 
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 Associating the observation with possible changes in actin 
cytoskeleton organization, we stained for F-actin and measured the spread 
width of actin in three different planes of individual cells. F-actin in 
hepatocytes cultured in the SCBA was mainly located in the cell cortex 
(cortical actin), and exhibited low spread width with small deviations, 
Figure 5.6 Actin distribution and quantification (A) Actin confocal imaging on top, middle and bottom planes of cells under perfusion in SCBA, static, sandwich and in vivo liver tissue viewed through window model. White arrow heads indicate the sampling line to measure actin fiber spread widths.  (B) Quantification of actin fibre spread width on top (red), middle (green) and bottom (blue) planes. N=50-100 from 2 independent experiments. (C) 3D re-construction via surface rendering for actin (green) and nucleus (blue). Top-left (TL): Perfusion; Top-right (TR): Monolayer; Bottom-left (BL): Collagen sandwich; Bottom-right (BR): in vivo liver tissue. 
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similar to that observed in vivo (Figure 5.6A and B). In contrast, cells in 
static culture exhibited thick actin bundles in all planes which were not 
localized to the cell cortex. And in collagen sandwich culture, thick actin 
fibres were only observed close to the cell-substrate interface; in other 
planes where there was no cell-cell or cell-ECM interactions, thin cortical 
actin fibres were observed (Figure 5.6A and B). Through 3D 
reconstruction of the actin cytoskeleton via surface rendering, we found 
that the distribution of actin in cells cultured in SCBA was indeed 
reminiscent of that in vivo. In contrast, randomly distributed stress fibers 
were found above and below the nucleus for cells cultured under static 
conditions. (Figure 5.6C).  
The presence of stress fibers, or contractile actomyosin fibers, is 
indicative that cells are under mechanical stress[46]. Given that stress 
fiber thickness and the degree of mechanical stress are correlated[47], the 
thick fibers present in the top and middle planes of flattened, spread cells 
grown as monolayers in static culture suggest that mechanical stress is 
present and transmitted throughout the cell body. For the collagen 
sandwich cultures, though stress fibers were present at the cell-substrate 
interfaces, the level of stress was much lower in the middle plane (Figure 
5.6B). Notably, the formation of more intense stress fibers in the collagen 
sandwich culture as compared to static monolayer culture might be due to 
the mechanical stress exerted by the accumulation of bile in the bile 
canaliculi (unpublished data). Lastly, that cells cultured under perfusion in 
our SCBA system exhibited in vivo-like organization of actin despite 
being cultured as monolayers suggests that the provision of mechanical 
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compaction simulated the forces sensed by cells in vivo, therefore 
resulting in the preservation of physical architecture of cortical actin. 
Given that the SCBA is able to maintain a cuboidal hepatocyte 
morphology in the absence of any additional overlay of ECM (typically in 
collagen sandwich culture), potential drug adsorption problems associated 
with the use of an overlay may be avoided[72].  
 
5.4 Conclusion 
In summary, the SCBA provides a working prototype to scale up 
the previously reported microfluidic-based cell compaction system 
from single microchannel to multi-wells. This system also provides 
improved control over the application and distribution of compaction. 
The perfusion flow rate could be optimized to achieve enhanced liver-
specific functions throughout the culture durations. Furthermore, the 
re-establishment of polarity was accelerated as compared to the static 
controls. Lastly, the distribution of cytoskeleton actin was found to 
mimic that of cells in vivo. As a novel engineering tool to modulate cell 
Figure 5.7 Actin similarity between ex vivo and in vivo samples Left: Actin (green) and nuclear (blue) staining of fixed liver tissue (ex vivo); Right: Actin (green) of live liver tissue in life-act mouse (in vivo) 
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compaction and intercellular interactions, this SCBA platform is a 
promising approach to confer tight control over hepatocyte 
repolarization for long-term in vitro culture. 
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Chapter 6. Conclusions and Future Work 
6.1 Conclusions 
This thesis has presented the application of mechanobiology principles in 
scaling up a microfluidic proof-of-concept perfusion culture device, using 
manual compaction into multi-well bioreactors via incorporations of 
compaction in addition to perfusion culture. Thermoplastic PMMA was chosen 
to fabricate the main body of the reactor instead of PDMS so as to facilitate 
low-cost and robust mass production. A novel “vertical flow” design was 
adopted to control the compaction in a uniform and quantifiable manner in the 
multi-well array. Microporous membranes coated with collagen was used as the 
cell seeding substrate as well as the generation of compaction. 
Hepatocytes, as an important cell type utilized in drug toxicology testing 
systems to mimic drug metabolism in liver, has been maintained over a long 
term with enhanced hepatic functions and polarities. The bioreactor was 
optimized in the flow distributor design, cell seeding density as well as 
compaction pressure through flow rate to achieve a working condition.  
During the validation experiments, hepatocyte-specific functions has been 
either maintained or enhanced in the long term culture. The polarity re-
establishment was accelerated, in accordance with the data obtained in the POC 
device. Notably, cytoskeleton actin was found to in distributions similar to an in 
vivo liver and ex vivo tissue samples without any support of ECM scaffold or 
overlays. This feature may help in culturing cells in a 3D morphology without 
causing adsorptions by supporting materials, a highly favored trait in drug 
testing applications.  
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In conclusion, the SCBA is a promising modular and high-throughput 
drug testing platform, with an adequate cell number per test, tight control over 
hepatocyte repolarization and intercellular interactions, as well as improved cell 
functions for long-term in vitro culture. 
 
6.2 Recommendations 
In the field of biotechnology, bringing a concept from a lab bench 
prototype to a commercial product may easily mean decades of R&D work in 
transformation, optimization, industrialization, etc. The difficulties lie in 
fluctuations in device performance due to material and process change, cell 
behavior change due to microenvironment change, or even a system-wide 
change in order to achieve more uniform and robust control in high-throughput 
or even automated systems. This thesis marks an important step in pushing 
forward POC prototypes into application systems, but also sheds lights on in 
vitro cell culture models for scientific works. 
Firstly, industry level production work intrinsically requires large volumes 
and a robust process in order to achieve a low per-piece cost. Even though this 
thesis aims for practical applications, there is still a lot of process and material 
optimization work needed for product development. For example, the PMMA 
main body was processed by machining and bonding, which may generate lots 
of rough surface to cause additional chemical adsorption in the media. However, 
when it comes to the stage to pilot production of this device, injection molding 
could be applied and a smooth finishing surface may be achieved. But during 
the manual prototyping stage now, it is too costly to fabricate a mold due to the 
small volume. Therefore, further work could be done during product 
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development in future on testing of adsorption rate of all the wetting material 
(on a smooth finishing surface), surface modification to lower the absorption 
rate, perfusion tubing optimization to reduce the dead volume of perfusate, etc.  
Cell seeding procedures may also be further simplified in order to achieve 
higher working efficiency, lower cellular environmental hazards and user-
friendly interface. Optimizing the seeding process into a multi-well module or 
equivalent may be a convenient solution to shorten the operation time and avoid 
errors during large-volume or routine tests. 
Notably, many current cell culture methods are performed under normal 
atmospheric pressures. However, when the cells grow in vivo, they undergo 
various pressures from the neighboring cells, vascular systems, organ capsula or 
even external forces. Therefore, the additional of compaction in a culture device 
is essential for truly biomimetic models. More research with the application of 
the important mechanobiology factor “compaction” in various scales should be 
done following this work. 
Last but not least, as cells in vivo do not only experience various 
mechanical stimuli in the microenvironment but also affected greatly by their 
neighbor cells with a number of different cell types. Taking in consideration of 
compaction in the culture is a good step to mimic the in vivo situation but if a 
co-culture between hepatocytes and other cell types may be incorporated, it 
would be a more interesting and biomimetic model to explore. 
 
   112
Reference List 
[1] D.-H. Kim, P. K. Wong, J. Park, A. Levchenko, and Y. Sun, “Microengineered Platforms for Cell Mechanobiology,” Annu. Rev. Biomed. Eng., vol. 11, no. 1, pp. 203–233, 2009. 
[2] M. C. H. van der Meulen and R. Huiskes, “Why mechanobiology?,” J. Biomech., vol. 35, no. 4, pp. 401–414, 2002. 
[3] T. Lee and S.-M. Yoon, “The Role of Intra-abdominal Pressure Measurement in Awake Rat Cystometry.,” Int. Neurourol. J., vol. 17, no. 2, pp. 44–7, 2013. 
[4] B. L. De Keulenaer, J. J. De Waele, B. Powell, and M. L. N. G. Malbrain, “What is normal intra-abdominal pressure and how is it affected by positioning, body mass and positive end-expiratory pressure?,” Intensive Care Med., vol. 35, no. 6, pp. 969–976, 2009. 
[5] P. Godoy, N. J. Hewitt, U. Albrecht, M. E. Andersen, N. Ansari, S. Bhattacharya, J. G. Bode, J. Bolleyn, C. Borner, J. Böttger, A. Braeuning, R. A. Budinsky, B. Burkhardt, N. R. Cameron, G. Camussi, C.-S. Cho, Y.-J. Choi, J. Craig Rowlands, U. Dahmen, G. Damm, O. Dirsch, M. T. Donato, J. Dong, S. Dooley, D. Drasdo, R. Eakins, K. S. Ferreira, V. Fonsato, J. Fraczek, R. Gebhardt, A. Gibson, M. Glanemann, C. E. P. Goldring, M. J. Gómez-Lechón, G. M. M. Groothuis, L. Gustavsson, C. Guyot, D. Hallifax, S. Hammad, A. Hayward, D. Häussinger, C. Hellerbrand, P. Hewitt, S. Hoehme, H.-G. Holzhütter, J. B. Houston, J. Hrach, K. Ito, H. Jaeschke, V. Keitel, J. M. Kelm, B. Kevin Park, C. Kordes, G. A. Kullak-Ublick, E. L. LeCluyse, P. Lu, J. Luebke-Wheeler, A. Lutz, D. J. Maltman, M. Matz-Soja, P. McMullen, I. Merfort, S. Messner, C. Meyer, J. Mwinyi, D. J. Naisbitt, A. K. Nussler, P. Olinga, F. Pampaloni, J. Pi, L. Pluta, S. A. Przyborski, A. Ramachandran, V. Rogiers, C. Rowe, C. Schelcher, K. Schmich, M. Schwarz, B. Singh, E. H. K. Stelzer, B. Stieger, R. Stöber, Y. Sugiyama, C. Tetta, W. E. Thasler, T. Vanhaecke, M. Vinken, T. S. Weiss, A. Widera, C. G. Woods, J. J. Xu, K. M. Yarborough, and J. G. Hengstler, Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME, vol. 87, no. 8. 2013. 
[6] S. N. Bhatia and D. E. Ingber, “Microfluidic organs-on-chips.,” Nat. Biotechnol., vol. 32, no. 8, pp. 760–772, 2014. 
[7] J. Barthes, H. Ozçelik, M. Hindié, A. Ndreu-Halili, A. Hasan, and N. E. Vrana, “Cell Microenvironment Engineering and Monitoring for Tissue Engineering and Regenerative Medicine: The Recent Advances.,” Biomed Res. Int., vol. 2014, no. i, p. 921905, 2014. 
[8] D. M. Vasudevan, S. S, and K. Vaidyanathan, Textbook of Biochemistry for Medical Students. JP Medical Ltd, 2013. 
[9] P. Fernandez and A. R. Bausch, “The compaction of gels by cells: a case of collective mechanical activity.,” Integr. Biol. (Camb)., vol. 1, no. 3, pp. 252–259, 2009. 
[10] A. Tijore, P. Cai, M. H. Nai, L. Zhuyun, W. Yu, C. Y. Tay, C. T. Lim, X. Chen, and L. P. Tan, “Role of Cytoskeletal Tension in the Induction of Cardiomyogenic Differentiation in Micropatterned Human Mesenchymal Stem 
   113
Cell.,” Adv. Healthc. Mater., pp. 1399–1407, 2015. 
[11] T. Gong, K. Zhao, G. Yang, J. Li, H. Chen, Y. Chen, and S. Zhou, “The control of mesenchymal stem cell differentiation using dynamically tunable surface microgrooves.,” Adv. Healthc. Mater., vol. 3, no. 10, pp. 1608–19, 2014. 
[12] Y. C. Toh, S. Ng, Y. M. Khong, X. Zhang, Y. Zhu, P. C. Lin, C. M. Te, W. Sun, and H. Yu, “Cellular responses to a nanofibrous environment,” Nano Today, vol. 1, no. 3, pp. 34–43, 2006. 
[13] Y.-C. Toh, C. Zhang, J. Zhang, Y. M. Khong, S. Chang, V. D. Samper, D. van Noort, D. W. Hutmacher, and H. Yu, “A novel 3D mammalian cell perfusion-culture system in microfluidic channels.,” Lab Chip, vol. 7, no. 3, pp. 302–309, 2007. 
[14] Y.-C. Toh, T. C. Lim, D. Tai, G. Xiao, D. van Noort, and H. Yu, “A microfluidic 3D hepatocyte chip for drug toxicity testing.,” Lab Chip, vol. 9, no. 14, pp. 2026–2035, 2009. 
[15] Y. Wang, Y.-C. Toh, Q. Li, B. Nugraha, B. Zheng, T. B. Lu, Y. Gao, M. M. L. Ng, and H. Yu, “Mechanical compaction directly modulates the dynamics of bile canaliculi formation.,” Integr. Biol. (Camb)., vol. 5, no. 2, pp. 390–401, 2013. 
[16] R. Bott, “When PDMS isn’t the best,” Anal. Chem., no. 1, p. 3249, 2007. 
[17] Fikst Product Development, “Fikst is pleased to announce that we have added microfluidic device manufacturing capabilities to our suite of engineering services,” 2014. [Online]. Available: http://www.fikst.com/pubs/DeviceMfgNewsletter.pdf. 
[18] M. W. Toepke and D. J. Beebe, “PDMS absorption of small molecules and consequences in microfluidic applications,” no. c, pp. 1484–1486, 2006. 
[19] N. Li, M. Schwartz, and C. Ionescu-Zanetti, “PDMS compound adsorption in context,” J. Biomol. …, vol. 14, no. 2, pp. 194–202, 2009. 
[20] G. Theodoridis, M. Aikaterini Lontou, F. Michopoulos, M. Sucha, and T. Gondova, “Study of multiple solid-phase microextraction combined off-line with high performance liquid chromatography,” Anal. Chim. Acta, vol. 516, no. 1–2, pp. 197–204, 2004. 
[21] G. Ocvirk, M. Munroe, T. Tang, R. Oleschuk, K. Westra, and D. J. Harrison, “Electrokinetic control of fluid flow in native poly(dimethylsiloxane) capillary electrophoresis devices,” Electrophoresis, vol. 21, no. 1, pp. 107–115, 2000. 
[22] “PMMA.” [Online]. Available: http://www.matbase.com/material-categories/natural-and-synthetic-polymers/commodity-polymers/material-properties-of-polymethyl-methacrylate-extruded-acrylic-pmma.html#properties. 
[23] T. Aziz, M. Waters, and R. Jagger, “Analysis of the properties of silicone rubber maxillofacial prosthetic materials,” J. Dent., vol. 31, no. 1, pp. 67–74, 2003. 
[24] D. E. Jaalouk and J. Lammerding, “Mechanotransduction gone awry.,” Nat. Rev. Mol. Cell Biol., vol. 10, no. 1, pp. 63–73, 2009. 
[25] D. P. Byrne, D. Lacroix, J. A. Planell, D. J. Kelly, and P. J. Prendergast, “Simulation of tissue differentiation in a scaffold as a function of porosity, Young’s modulus and dissolution rate: Application of mechanobiological models in tissue engineering,” Biomaterials, vol. 28, no. 36, pp. 5544–5554, 2007. 
   114
[26]  a. Boccaccio, A. Messina, C. Pappalettere, and M. Scaraggi, Computational Modelling of Biomechanics and Biotribology in the Musculoskeletal System. Elsevier Science, 2014. 
[27] M. A. Fernandez-Yague, S. A. Abbah, L. McNamara, D. I. Zeugolis, A. Pandit, M. J. Biggs, A. Tijore, P. Cai, M. H. Nai, L. Zhuyun, W. Yu, C. Y. Tay, C. T. Lim, X. Chen, and L. P. Tan, “Biomimetic Approaches in Bone Tissue Engineering: Integrating Biological and Physicomechanical Strategies,” Adv. Healthc. Mater., vol. 84, pp. 1–29, 2014. 
[28] D. R. Carter, P. R. Blenman, and G. S. Beaupré, “Correlations between mechanical stress history and tissue differentiation in initial fracture healing.,” J. Orthop. Res., vol. 6, no. 5, pp. 736–748, 1988. 
[29] T. Lecuit and P. Lenne, “Cell surface mechanics and the control of cell shape , tissue patterns and morphogenesis,” vol. 8, no. August, pp. 633–644, 2007. 
[30] M. A. Fernandez-Yague, S. A. Abbah, L. McNamara, D. I. Zeugolis, A. Pandit, and M. J. Biggs, “Biomimetic Approaches in Bone Tissue Engineering: Integrating Biological and Physicomechanical Strategies,” Adv. Drug Deliv. Rev., vol. 84, pp. 1–29, 2014. 
[31] L.-L. Pontani, I. Jorjadze, V. Viasnoff, and J. Brujic, “Biomimetic emulsions reveal the effect of mechanical forces on cell-cell adhesion,” Proc. Natl. Acad. Sci., vol. 109, no. 25, pp. 9839–9844, 2012. 
[32] F. Xiong, W. Ma, T. W. Hiscock, K. R. Mosaliganti, A. R. Tentner, K. A. Brakke, N. Rannou, A. Gelas, L. Souhait, I. A. Swinburne, N. D. Obholzer, and S. G. Megason, “Interplay of Cell Shape and Division Orientation Promotes Robust Morphogenesis of Developing Epithelia,” Cell, vol. 159, no. 2, pp. 415–427, 2014. 
[33] E. J. Semler, P. A. Lancin, A. Dasgupta, and P. V. Moghe, “Engineering hepatocellular morphogenesis and function via ligand-presenting hydrogels with graded mechanical compliance,” Biotechnol. Bioeng., vol. 89, no. 3, pp. 296–307, 2005. 
[34] Y. Sakai, S. Yamagami, and K. Nakazawa, “Comparative analysis of gene expression in rat liver tissue and monolayer- and spheroid-cultured hepatocytes,” Cells Tissues Organs, vol. 191, no. 4, pp. 281–288, 2010. 
[35] C. R. Wittmer, J. A. Phelps, C. M. Lepus, W. M. Saltzman, M. J. Harding, and P. R. Van Tassel, “Multilayer nanofilms as substrates for hepatocellular applications,” Biomaterials, vol. 29, no. 30, pp. 4082–4090, 2008. 
[36] J. P. Wikswo, E. L. Curtis, Z. E. Eagleton, B. C. Evans, A. Kole, L. H. Hofmeister, and W. J. Matloff, “Scaling and systems biology for integrating multiple organs-on-a-chip.,” Lab Chip, vol. 13, no. 18, pp. 3496–511, 2013. 
[37] M. R. Ebrahimkhani, J. a S. Neiman, M. S. B. Raredon, D. J. Hughes, and L. G. Griffith, “Bioreactor technologies to support liver function in vitro,” Adv. Drug Deliv. Rev., vol. 69–70, pp. 132–157, 2014. 
[38] Y. Nahmias, F. Berthiaume, and M. L. Yarmush, “Integration of technologies for hepatic tissue engineering,” Adv. Biochem. Eng. Biotechnol., vol. 103, no. September, pp. 309–329, 2006. 
[39] Y. Tanaka, M. Yamato, T. Okano, T. Kitamori, and K. Sato, “Evaluation of effects of shear stress on hepatocytes by a microchip-based system,” Meas. Sci. Technol., vol. 17, no. 12, pp. 3167–3170, 2006. 
   115
[40]  a I. Musat, C. a Sattler, G. L. Sattler, and H. C. Pitot, “Reestablishment of cell polarity of rat hepatocytes in primary culture.,” Hepatology, vol. 18, no. 1, pp. 198–205, 1993. 
[41] B. Vollmar and M. D. Menger, “The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair.,” Physiol. Rev., vol. 89, no. 4, pp. 1269–1339, 2009. 
[42] I. Encyclopædia Britannica, “liver: structure of human liver,” Art. Encyclopædia Britannica Online. Web. . 
[43] “Stress Fiber,” Wikipedia. 2015. 
[44] M. Chrzanowska-Wodnicka and K. Burridge, “Rho-stimulated contractility drives the formation of stress fibers and focal adhesions.,” J. Cell Biol., vol. 133, no. 6, pp. 1403–15, 1996. 
[45] K. Burridge, “Are stress fibers contractile?,” Nature, vol. 294. pp. 691–692, 1981. 
[46] S. Tojkander, G. Gateva, and P. Lappalainen, “Actin stress fibers - assembly, dynamics and biological roles,” J. Cell Sci., vol. 125, no. 8, pp. 1855–1864, 2012. 
[47] C. S. Chen, J. Tan, and J. Tien, “Mechanotransduction at cell-matrix and cell-cell contacts.,” Annu. Rev. Biomed. Eng., vol. 6, pp. 275–302, 2004. 
[48] L. M. Arterburn, J. Zurlo, J. D. Yager, R. M. Overton, and  a H. Heifetz, “A morphological study of differentiated hepatocytes in vitro.,” Hepatology, vol. 22, no. 1, pp. 175–187, 1995. 
[49] J. Dich, C. Vind, and N. Grunnet, “Long-term culture of hepatocytes: effect of hormones on enzyme activities and metabolic capacity,” Hepatology, vol. 8, no. 1, pp. 39–45, 1988. 
[50] D. St Johnston and B. Sanson, “Epithelial polarity and morphogenesis,” Curr. Opin. Cell Biol., vol. 23, no. 5, pp. 540–546, 2011. 
[51] D. L. Clemens, “Use of cultured cells to study alcohol metabolism.,” Alcohol Res. Health, vol. 29, no. 4, pp. 291–295, 2006. 
[52] M. J. Phillips, C. Oshio, M. Miyairi, H. Katz, and C. R. Smith, “A study of bile canalicular contractions in isolated hepatocytes.,” Hepatology, vol. 2, no. 6, pp. 763–8, 1982. 
[53] M. A. Treyer A, “Hepatocyte polarity,” Compr. Physiol., vol. 3, pp. 243–287, 2013. 
[54] G. A. Kullak-ublick, B. Stieger, and P. J. Meier, “Enterohepatic bile salt transporters in normal physiology and liver disease,” Gastroenterology, vol. 126, no. 1, pp. 322–342, 2004. 
[55] H. N. Higgs and K. J. Peterson, “Phylogenetic analysis of the formin homology 2 domain.,” Mol. Biol. Cell, vol. 16, no. 1, pp. 1–13, 2005. 
[56] Y. Du, R. Han, F. Wen, S. Ng San San, L. Xia, T. Wohland, H. L. Leo, and H. Yu, “Synthetic sandwich culture of 3D hepatocyte monolayer,” Biomaterials, vol. 29, no. 3, pp. 290–301, 2008. 
[57] Y. Du, R. Han, S. Ng, J. Ni, W. Sun, T. Wohland, S.-H. Ong, L. Kuleshova, and H. Yu, “Identification and characterization of a novel prespheroid 3-dimensional hepatocyte monolayer on galactosylated substratum.,” Tissue Eng., 
   116
vol. 13, no. 7, pp. 1455–1468, 2007. 
[58] S. Ng, R. Han, S. Chang, J. Ni, W. Hunziker, A. B. Goryachev, S. H. Ong, and H. Yu, “Improved hepatocyte excretory function by immediate presentation of polarity cues.,” Tissue Eng., vol. 12, no. 8, pp. 2181–2191, 2006. 
[59] Y. Nakao, H. Kimura, Y. Sakai, and T. Fujii, “Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device,” Biomicrofluidics, vol. 5, no. 2, pp. 1–7, 2011. 
[60] H. Matsui, T. Osada, Y. Moroshita, M. Sekijima, T. Fujii, S. Takeuchi, and Y. Sakai, “Rapid and enhanced repolarization in sandwich-cultured hepatocytes on an oxygen-permeable membrane,” Biochem. Eng. J., vol. 52, no. 2–3, pp. 255–262, 2010. 
[61] M. A. Brady, M. P. Lewis, and V. Mudera, “Synergy between myogenic and non-myogenic cells in a 3D tissue-engineered craniofacial skeletal muscle construct,” J. Tissue Eng. Regen. Med., vol. 2, pp. 408–417, 2008. 
[62] M. Anraku, R. Shintomo, K. Taguchi, U. Kragh-hansen, T. Kai, T. Maruyama, and M. Otagiri, “Amino acids of importance for the antioxidant activity of human serum albumin as revealed by recombinant mutants and genetic variants,” Life Sci., vol. 134, pp. 36–41, 2015. 
[63] H. C. Isom and I. Georgoff, “Quantitative assay for albumin-producing liver cells after simian virus 40 transformation of rat hepatocytes maintained in chemically defined medium.,” Proc. Natl. Acad. Sci. U. S. A., vol. 81, no. 20, pp. 6378–82, 1984. 
[64] M. T. Donato, A. Lahoz, S. Montero, A. Bonora, E. Pareja, J. Mir, J. V Castell, and M. J. Gómez-Lechón, “Functional assessment of the quality of human hepatocyte preparations for cell transplantation.,” Cell Transplant., vol. 17, no. 10–11, pp. 1211–9, 2008. 
[65] T. De Bruyn, S. Chatterjee, S. Fattah, J. Keemink, J. Nicolaï, P. Augustijns, and P. Annaert, “Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity.,” Expert Opin. Drug Metab. Toxicol., vol. 9, no. 5, pp. 589–616, 2013. 
[66] Y. Tanaka, M. Yamato, T. Okano, T. Kitamori, and K. Sato, “Evaluation of effects of shear stress on hepatocytes by a microchip-based system,” Meas. Sci. Technol., vol. 17, no. 12, pp. 3167–3170, 2006. 
[67] V. V. Y. Soldatow, E. E. L. Lecluyse, L. L. G. Griffith, and I. Rusyn, “In vitro models for liver toxicity testing,” Toxicol. Res. (Camb)., vol. 2, no. 1, pp. 23–39, 2013. 
[68] D. Haouzi, S. Baghdiguian, G. Granier, P. Travo, P. Mangeat, and U. Hibner, “Three-dimensional polarization sensitizes hepatocytes to Fas/CD95 apoptotic signalling.,” J. Cell Sci., vol. 118, no. Pt 12, pp. 2763–2773, 2005. 
[69] L. Xia, R. B. Sakban, Y. Qu, X. Hong, W. Zhang, B. Nugraha, W. H. Tong, A. Ananthanarayanan, B. Zheng, I. Y.-Y. Chau, R. Jia, M. McMillian, J. Silva, S. Dallas, and H. Yu, “Tethered spheroids as an in vitro hepatocyte model for drug safety screening,” Biomaterials, vol. 33, no. 7, pp. 2165–2176, 2012. 
[70] F. Molina-Jimenez, I. Benedicto, V. L. Dao Thi, V. Gondar, D. Lavillette, J. J. Marin, O. Briz, R. Moreno-Otero, R. Aldabe, T. F. Baumert, F. L. Cosset, M. Lopez-Cabrera, and P. L. Majano, “Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle,” 
   117
Virology, vol. 425, no. 1, pp. 31–39, 2012. 
[71] J. C. Dunn, R. G. Tompkins, and M. L. Yarmush, “Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation.,” J. Cell Biol., vol. 116, no. 4, pp. 1043–53, 1992. 
[72] B. Nugraha, X. Hong, X. Mo, L. Tan, W. Zhang, P. M. Chan, C. H. Kang, Y. Wang, L. T. Beng, W. Sun, D. Choudhury, J. M. Robens, M. McMillian, J. Silva, S. Dallas, C. H. Tan, Z. Yue, and H. Yu, “Galactosylated cellulosic sponge for multi-well drug safety testing,” Biomaterials, vol. 32, no. 29, pp. 6982–6994, 2011. 
[73] S. Mueller and L. Sandrin, “Liver stiffness: a novel parameter for the diagnosis of liver disease.,” Hepatic Med. Evid. Res., vol. 2, p. 49, 2010. 
[74] S. Jana, A. Lerman, and R. D. Simari, “An In Vitro Model of a Fibrosa Layer of a Heart Valve An In Vitro Model of a Fibrosa Layer of a Heart Valve University of Kansas School of Medicine,” 2015. 
[75] E. J. Semler and P. V. Moghe, “Engineering hepatocyte functional fate through growth factor dynamics: The role of cell morphologic priming,” Biotechnol. Bioeng., vol. 75, pp. 510–520, 2001. 
[76] R. Turner, O. Lozoya, Y. Wang, V. Cardinale, E. Gaudio, G. Alpini, G. Mendel, E. Wauthier, C. Barbier, D. Alvaro, and L. M. Reid, “Human hepatic stem cell and maturational liver lineage biology,” Hepatology, vol. 53, no. 3, pp. 1035–1045, 2011. 
[77] J. Zoldan, E. D. Karagiannis, C. Y. Lee, D. G. Anderson, R. Langer, and S. Levenberg, “The influence of scaffold elasticity on germ layer specification of human embryonic stem cells,” Biomaterials, vol. 32, no. 36, pp. 9612–9621, 2011. 
[78] O. a. Lozoya, E. Wauthier, R. a. Turner, C. Barbier, G. D. Prestwich, F. Guilak, R. Superfine, S. R. Lubkin, and L. M. Reid, “Regulation of hepatic stem/progenitor phenotype by microenvironment stiffness in hydrogel models of the human liver stem cell niche,” Biomaterials, vol. 32, no. 30, pp. 7389–402, 2011. 
[79] L. M. Flendrig, J. W. La Soe, G. G. a Jörning, A. Steenbeek, O. T. Karlsen, W. M. M. J. Bovée, N. C. J. J. Ladiges, A. a. Te Velde, and R. a F. M. Chamuleau, “In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates,” J. Hepatol., vol. 26, no. 6, pp. 1379–1392, 1997. 
[80] H. O. Jauregui, S. Naik, H. Santangini, J. Pan, D. Trenkler, and C. Mullon, “Primary cultures of rat hepatocytes in hollow fiber chambers.,” In Vitro Cell. Dev. Biol. Anim., vol. 30A, no. 1, pp. 23–29, 1994. 
[81] C. F. Wolf and B. E. Munkelt, “Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries.,” Transactions - American Society for Artificial Internal Organs, vol. 21. pp. 16–27, 1975. 
[82] H. Miyoshi, K. Yanagi, H. Fukuda, and N. Ohshima, “Long-term performance of albumin secretion of hepatocytes cultured in a packed-bed reactor utilizing porous resin.,” Artif. Organs, vol. 20, no. 7, pp. 803–807, 1996. 
[83] J.-P. Chen and C.-T. Lin, “Dynamic seeding and perfusion culture of hepatocytes with galactosylated vegetable sponge in packed-bed bioreactor.,” J. Biosci. Bioeng., vol. 102, no. 1, pp. 41–45, 2006. 
   118
[84] L. Xia, T. Arooz, S. Zhang, X. Tuo, G. Xiao, T. A. K. Susanto, J. Sundararajan, T. Cheng, Y. Kang, H. J. Poh, H. L. Leo, and H. Yu, “Hepatocyte function within a stacked double sandwich culture plate cylindrical bioreactor for bioartificial liver system,” Biomaterials, vol. 33, no. 32, pp. 7925–7932, 2012. 
[85] T. D. Whitehead, S. T. Nemanich, C. Dence, and K. I. Shoghi, “A PET-Compatible Tissue Bioreactor for Research, Discovery, and Validation of Imaging Biomarkers and Radiopharmaceuticals: System Design and Proof-of-Concept Studies,” J. Nucl. Med., vol. 54, no. 10, pp. 1812–1819, 2013. 
[86] A. W. Tilles, H. Baskaran, P. Roy, M. L. Yarmush, and M. Toner, “Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor,” Biotechnol. Bioeng., vol. 73, no. 5, pp. 379–389, 2001. 
[87] M. S. Kim, J. H. Yeon, and J. K. Park, “A microfluidic platform for 3-dimensional cell culture and cell-based assays,” Biomed. Microdevices, vol. 9, no. 1, pp. 25–34, 2007. 
[88] U. Fernekorn, J. Hampl, C. Augspurger, C. Hildmann, F. Weise, M. Klett, A. Läffert, M. Gebinoga, A. Williamson, and A. Schober, “In vitro cultivation of biopsy derived primary hepatocytes leads to a more metabolic genotype in perfused 3D scaffolds than static 3D cell culture,” RSC Adv., vol. 3, no. 37, p. 16558, 2013. 
[89] L. Ma, J. Barker, C. Zhou, W. Li, J. Zhang, B. Lin, G. Foltz, J. Küblbeck, and P. Honkakoski, “Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system,” Biomaterials, vol. 33, no. 17, pp. 4353–4361, 2012. 
[90] C. Y. Chan, P. Huang, F. Guo, X. Ding, V. Kapur, J. D. Mai, P. K. Yuen, and T. J. Huang, “Accelerating drug discovery via organs-on-chips,” Lab Chip, vol. 13, pp. 4697–4710, 2013. 
[91] U. Marx, H. Walles, S. Hoffmann, G. Lindner, R. Horland, F. Sonntag, U. Klotzbach, D. Sakharov, A. Tonevitsky, and R. Lauster, “‘Human-on-a-chip’ developments: A translational cuttingedge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man?,” ATLA Altern. to Lab. Anim., vol. 40, no. 5, pp. 235–257, 2012. 
[92] I. Wagner, E.-M. Materne, S. Brincker, U. Süssbier, C. Frädrich, M. Busek, F. Sonntag, D. a Sakharov, E. V Trushkin, A. G. Tonevitsky, R. Lauster, and U. Marx, “A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture.,” Lab Chip, vol. 13, no. 18, pp. 3538–47, 2013. 
[93]  and T. M. Chen, A. M.L. Yarmush, “Physiologically Based Pharmacokinetic Models: Integration of In Silico Approaches with Micro Cell Culture Analogues,” Curr Drug Metab., vol. 13, no. 6, pp. 863–880, 2012. 
[94] K. Domansky, W. Inman, J. Serdy, A. Dash, M.H. Lim, L.G.Griffith, K. Domansky, W. Inman, J. Serdy, A. Dash, M. H. M. Lim, and L. G. Griffith, “Perfused multiwell plate for 3D liver tissue engineering.,” Lab Chip, vol. 10, no. 1, pp. 51–58, 2014. 
[95] S. Zhang, W. Tong, B. Zheng, T. a K. Susanto, L. Xia, C. Zhang, A. Ananthanarayanan, X. Tuo, R. B. Sakban, R. Jia, C. Iliescu, K. H. Chai, M. McMillian, S. Shen, H. Leo, and H. Yu, “A robust high-throughput sandwich cell-based drug screening platform,” Biomaterials, vol. 32, no. 4, pp. 1229–1241, 2011. 
   119
[96] G. D. S. Tan, G. W. Toh, E. Birgersson, J. Robens, D. van Noort, and H. L. Leo, “A thin-walled polydimethylsiloxane bioreactor for high-density hepatocyte sandwich culture,” Biotechnol. Bioeng., vol. 110, no. 6, pp. 1663–1673, 2013. 
[97] S. J. Trietsch, G. D. Israëls, J. Joore, T. Hankemeier, and P. Vulto, “Microfluidic titer plate for stratified 3D cell culture.,” Lab Chip, vol. 13, no. 18, pp. 3548–3554, 2013. 
[98] L. J. Nelson, S. W. Walker, P. C. Hayes, and J. N. Plevris, “Low-shear modelled microgravity environment maintains morphology and differentiated functionality of primary porcine hepatocyte cultures,” Cells Tissues Organs, vol. 192, no. 2, pp. 125–140, 2010. 
[99] J. Kasuya, R. Sudo, T. Mitaka, M. Ikeda, and K. Tanishita, “Hepatic stellate cell-mediated three-dimensional hepatocyte and endothelial cell triculture model.,” Tissue Eng. Part A, vol. 17, no. 3–4, pp. 361–370, 2011. 
[100] J. Kasuya, R. Sudo, R. Tamogami, G. Masuda, T. Mitaka, M. Ikeda, and K. Tanishita, “Reconstruction of 3D stacked hepatocyte tissues using degradable, microporous poly(d,l-lactide-co-glycolide) membranes,” Biomaterials, vol. 33, no. 9, pp. 2693–2700, 2012. 
[101] H. F. Lu, K. N. Chua, P. C. Zhang, W. S. Lim, S. Ramakrishna, K. W. Leong, and H. Q. Mao, “Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance,” Acta Biomater., vol. 1, no. 4, pp. 399–410, 2005. 
[102] J. C. Dunn, R. G. Tompkins, and M. L. Yarmush, “Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration.,” Biotechnol. Prog., vol. 7, no. 3, pp. 237–245, 1991. 
[103] J. C. Y. Dunn, R. G. Tompkins, and M. L. Yarmush, “Hepatocytes in Collagen Sandwich :Evidencefor Transcriptional and Translational Regulation,” vol. 116, no. 4, pp. 1–11, 2002. 
[104] V. N. Goral, Y.-C. Hsieh, O. N. Petzold, J. S. Clark, P. K. Yuen, and R. a Faris, “Perfusion-based microfluidic device for three-dimensional dynamic primary human hepatocyte cell culture in the absence of biological or synthetic matrices or coagulants.,” Lab Chip, vol. 10, no. 24, pp. 3380–3386, 2010. 
[105] R. Baudoin, A. Corlu, L. Griscom, C. Legallais, and E. Leclerc, “Trends in the development of microfluidic cell biochips for in vitro hepatotoxicity,” Toxicol. Vitr., vol. 21, no. 4, pp. 535–544, 2007. 
[106] W. S. Redfern, L. C. Ewart, P. Lainée, M. Pinches, S. Robinson, and J.-P. Valentin, “Functional assessments in repeat-dose toxicity studies: the art of the possible,” Toxicol. Res. (Camb)., vol. 2, no. 4, p. 209, 2013. 
[107] E. Leclerc, F. Miyata, K. S. Furukawa, T. Ushida, Y. Sakai, and T. Fujii, “Effect on liver cells of stepwise microstructures fabricated in a photosensitive biodegradable polymer by softlithography,” Mater. Sci. Eng. C, vol. 24, no. 3, pp. 349–354, 2004. 
[108] S. Salerno, C. Campana, S. Morelli, E. Drioli, and L. De Bartolo, “Human hepatocytes and endothelial cells in organotypic membrane systems,” Biomaterials, vol. 32, no. 34, pp. 8848–8859, 2011. 
[109] H. Liu, Y. Yan, X. Wang, J. Cheng, F. Lin, Z. Xiong, and R. Wu, “Construct hepatic analog by cell-matrix controlled assembly technology,” Handb. Environ. Chem. Vol. 5 Water Pollut., vol. 51, no. 15, pp. 1830–1835, 2006. 
   120
[110] L. De Bartolo, S. Morelli, L. C. Lopez, L. Giorno, G. Barbieri, S. Salerno, M. Rende, E. Curcio, A. Procino, P. Favia, B. Memoli, V. E. Andreucci, R. d’Agostino, and E. Drioli, “Human galactosylated membrane bioreactor for the long-term maintenance of liver specific functions,” Desalination, vol. 199, no. 1–3, pp. 147–149, 2006. 
[111] L. De Bartolo, S. Salerno, S. Morelli, L. Giorno, M. Rende, B. Memoli, A. Procino, V. E. Andreucci, A. Bader, and E. Drioli, “Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor,” Biomaterials, vol. 27, no. 27, pp. 4794–4803, 2006. 
[112] E. Leclerc, Y. Sakai, and T. Fujii, “Microfluidic PDMS (Polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes,” Biotechnol. Prog., vol. 20, no. 3, pp. 750–755, 2004. 
[113] E. Leclerc, Y. Sakai, and T. Fujii, “Perfusion culture of fetal human hepatocytes in microfluidic environments,” Biochem. Eng. J., vol. 20, no. 2–3, pp. 143–148, 2004. 
[114] G. K. Michalopoulos, “Liver Regeneration after Partial Hepatectomy,” Ajpa, vol. 176, no. 1, pp. 2–13, 2010. 
[115] N. Fausto, “Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells,” Hepatology, vol. 39, no. 6, pp. 1477–1487, 2004. 
[116] Y. Chen, P. P. Wong, L. Sjeklocha, C. J. Steer, and M. B. Sahin, “Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture,” Hepatology, vol. 55, no. 2, pp. 563–574, Feb. 2012. 
[117] P. Roelandt, K. A. Pauwelyn, P. Sancho-Bru, K. Subramanian, B. Bose, L. Ordovas, K. Vanuytsel, M. Geraerts, M. Firpo, R. De Vos, J. Fevery, F. Nevens, W.-S. Hu, and C. M. Verfaillie, “Human Embryonic and Rat Adult Stem Cells with Primitive Endoderm-Like Phenotype Can Be Fated to Definitive Endoderm, and Finally Hepatocyte-Like Cells,” PLoS One, vol. 5, no. 8, p. e12101, 2010. 
[118] M. Baxter, S. Withey, S. Harrison, C.-P. Segeritz, F. Zhang, R. Atkinson-Dell, C. Rowe, D. T. Gerrard, R. Sison-Young, R. Jenkins, J. Henry, A. A. Berry, L. Mohamet, M. Best, S. W. Fenwick, H. Malik, N. R. Kitteringham, C. E. Goldring, K. Piper Hanley, L. Vallier, and N. A. Hanley, “Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes.,” J. Hepatol., vol. 62, no. 3, pp. 581–9, 2015. 
[119] J. Hakkola, E. Tanaka, and O. Pelkonen, “Developmental expression of cytochrome P450 enzymes in human liver.,” Pharmacol. Toxicol., vol. 82, no. 5, pp. 209–17, 1998. 
[120] Z. Yue, F. Wen, S. Gao, M. Y. Ang, P. K. Pallathadka, L. Liu, and H. Yu, “Preparation of three-dimensional interconnected macroporous cellulosic hydrogels for soft tissue engineering,” Biomaterials, vol. 31, no. 32, pp. 8141–8152, 2010. 
[121] A. Chander, “ILK, ECM composition and substrate rigidity regulate Focal adhesion - actin coupling,” COLUMBIA UNIVERSITY, 2012. 
[122] M. Imamura, T. Kojima, M. Lan, S. Son, M. Murata, M. Osanai, H. Chiba, K. Hirata, and N. Sawada, “Oncostatin M induces upregulation of claudin-2 in rodent hepatocytes coinciding with changes in morphology and function of tight junctions.,” Exp. Cell Res., vol. 313, no. 9, pp. 1951–62, 2007. 
   121
[123] D. Chen, C. R. M. Wilkinson, S. Watt, C. J. Penkett, W. M. Toone, N. Jones, and J. Bähler, “Multiple pathways differentially regulate global oxidative stress responses in fission yeast.,” Mol. Biol. Cell, vol. 19, no. 1, pp. 308–317, 2008. 
[124] M. Nakamura, T. Shinji, K. Ujike, S. Hirasaki, N. Koide, and T. Tsuji, “Cytoskeletal inhibitors, anti-adhesion molecule antibodies, and lectins inhibit hepatocyte spheroid formation.,” Acta Med. Okayama, vol. 56, no. 1, pp. 43–50, Feb. 2002. 
[125] K. Subramanian, D. J. Owens, R. Raju, M. Firpo, T. D. O’Brien, C. M. Verfaillie, and W.-S. Hu, “Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells.,” Stem Cells Dev., vol. 23, no. 2, pp. 124–31, 2014. 
[126] N. Funakoshi, C. Duret, J. M. Pascussi, P. Blanc, P. Maurel, M. Daujat-Chavanieu, and S. Gerbal-Chaloin, “Comparison of Hepatic-like Cell Production from Human Embryonic Stem Cells and Adult Liver Progenitor Cells: CAR Transduction Activates a Battery of Detoxification Genes,” Stem Cell Rev. Reports, vol. 7, no. 3, pp. 518–531, 2011. 
[127] G. Ginsberg, D. Hattis, B. Sonawane, A. Russ, P. Banati, M. Kozlak, S. Smolenski, and R. Goble, “Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature,” Toxicol. Sci., vol. 66, no. 2, pp. 185–200, 2002. 
[128] V. M. Piñeiro-Carrero and E. O. Piñeiro, “Liver.,” Pediatrics, vol. 113, no. 4 Suppl, pp. 1097–106, Apr. 2004. 
[129] A. J. Engler, S. Sen, H. L. Sweeney, and D. E. Discher, “Matrix Elasticity Directs Stem Cell Lineage Specification,” Cell, vol. 126, no. 4, pp. 677–689, 2006. 
[130] M. Tallawi, R. Rai, A. R. Boccaccini, and K. E. Aifantis, “Effect of Substrate Mechanics on Cardiomyocyte Maturation and Growth,” Tissue Eng. Part B Rev., vol. 21, no. 1, pp. 157–165, 2015. 
[131] C. M. Nelson and J. P. Gleghorn, “Sculpting Organs: Mechanical Regulation of Tissue Development,” Annu. Rev. Biomed. Eng., vol. 14, no. 1, pp. 129–154, 2012. 
[132]  a Kamiya, T. Kinoshita, Y. Ito, T. Matsui, Y. Morikawa, E. Senba, K. Nakashima, T. Taga, K. Yoshida, T. Kishimoto, and  a Miyajima, “Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.,” EMBO J., vol. 18, no. 8, pp. 2127–2136, 1999. 
[133] J.-O. De Craene, J. Coleman, P. E. de Martin, M. Pypaert, S. Anderson, J. R. Yates, III,  and P. N. Ferro-Novick, and *Department, “Rtn1p is involved in structuring the cortical endoplasmic reticulum,” Mol. Biol. Cell, vol. 17, no. June, pp. 3009–3020, 2006. 
[134] J.-O. De Craene, J. Coleman, P. E. de Martin, M. Pypaert, S. Anderson, J. R. Yates, III,  and P. N. Ferro-Novick, and *Department, “Rtn1p is involved in structuring the cortical endoplasmic reticulum,” Mol. Biol. Cell, vol. 17, no. July, pp. 3009–3020, 2006. 
[135] P. S. Gregory L. Kirk, Emanuele Ostuni, Enoch Kim, Olivier Schueller, “US 7374906 B2 Biological assays using gradients formed in microfluidic systems,” 2008. 
[136] L. Qiushi, Z. Yue, P. Pluchon, J. Robens, K. Herr, M. Mercade, J. Thiery, H. Yu, 
   122
and V. Viasnoff, “Extracellular matrix scaffolding guides lumen elongation by inducing anisotropic intercellular mechanical tension,” Nat. Cell Biol., vol. In Press, 2015. 
[137] L. De Bartolo, A. Leindlein, D. Hofmann, A. Bader, A. de Grey, E. Curcio, and E. Drioli, “Bio-hybrid organs and tissues for patient therapy: A future vision for 2030,” Chem. Eng. Process. Process Intensif., vol. 51, pp. 79–87, 2012. 
[138] H. M. Ji, V. Samper, Y. Chen, C. K. Heng, T. M. Lim, and L. Yobas, “Silicon-based microfilters for whole blood cell separation,” Biomed. Microdevices, vol. 10, no. 2, pp. 251–257, 2008. 
[139] W. S. Low, W. Abu, and B. Wan, “Benchtop Technologies for Circulating Tumor Cells Separation Based on Biophysical Properties,” vol. 2015, 2015. 
[140] H. J. Hoffmans, G.J.C.M. · Den Adel, H. · Verheij, “Shear stress concept in granular filters,” in 1st international conference on scour and erosion, Melbourne, 2000 (ICSE-1). 
[141] A. Cunningham, “Influence of biofilm accumulation on porous media hydrodynamics,” … Sci. Technol., pp. 1305–1311, 1991. 
[142] A. Folch and M. Toner, “Cellular micropatterns on biocompatible materials,” Biotechnol. Prog., vol. 14, no. 3, pp. 388–392, 1998. 
[143] G. Gonçalves, M. T. Portolés, C. Ramírez-Santillán, M. Vallet-Regí, A. P. Serro, J. Grácio, and P. a a P. Marques, “Evaluation of the in vitro biocompatibility of PMMA/high-load HA/carbon nanostructures bone cement formulations,” J. Mater. Sci. Mater. Med., vol. 24, no. 12, pp. 2787–2796, 2013. 
[144] C. Li, J. H. Hsieh, W. W. Hu, and Y. H. Lin, “Fabrication and characterization of polymethylmethacrylate (PMMA) thin film by plasma polymerization used for cell culture,” Surf. Coatings Technol., vol. 259, pp. 20–26, 2014. 
[145] A. P. Li, “Screening for human ADME/Tox drug properties in drug discovery,” Drug Discov. Today, vol. 6, no. 7, pp. 357–366, 2001. 
[146] Y. Sun, Y. C. Kwok, and N.-T. Nguyen, “Low-pressure, high-temperature thermal bonding of polymeric microfluidic devices and their applications for electrophoretic separation,” J. Micromechanics Microengineering, vol. 16, no. 8, pp. 1681–1688, 2006. 
[147] C. W. Tsao and D. L. DeVoe, “Bonding of thermoplastic polymer microfluidics,” Microfluid. Nanofluidics, vol. 6, no. 1, pp. 1–16, 2009. 
[148] M. B. Wabuyele, S. M. Ford, W. Stryjewski, J. Barrow, and S. a. Soper, “Single molecule detection of double-stranded DNA in poly(methylmethacrylate) and polycarbonate microfluidic devices,” Electrophoresis, vol. 22, no. 18, pp. 3939–3948, 2001. 
[149] Oxygen Transport to Tissue: Satellite Symposium of the 28th International Congress of Physiological Sciences, Budapest, Hungary, 1980. Elsevier Science, 2013. 
[150] S. Choi, M. G. Lee, and J. K. Parka, “Microfluidic parallel circuit for measurement of hydraulic resistance,” Biomicrofluidics, vol. 4, no. 3, 2010. 
[151] H. A. Hirsch, F. E. Loeffler, H. Ludwig, and K.-H. Wulf, Archives of Gynecology: Organ of the Deutsche Gesellschaft für Gynäkologie und Geburtshilfe. Springer, 2013. 
[152] P. Kan, H. Miyoshi, K. Yanagi, and N. Ohshima, “Effects of shear stress on 
   123
metabolic function of the co-culture system of hepatocyte/nonparenchymal cells for a bioartificial liver.,” ASAIO J., vol. 44, no. 5, pp. M441–M444, 1998. 
[153] H. Nakatsuka, T. Sokabe, K. Yamamoto, Y. Sato, K. Hatakeyama, A. Kamiya, J. Ando, H. Nakatsuka, T. Sokabe, K. Yamamoto, and Y. Sato, “Shear stress induces hepatocyte PAI-1 gene expression through cooperative Sp1 / Ets-1 activation of transcription,” pp. 26–34, 2008. 
[154] A. Alrifaiy, O. a. Lindahl, and K. Ramser, “Polymer-based microfluidic devices for pharmacy, biology and tissue engineering,” Polymers (Basel)., vol. 4, no. 3, pp. 1349–1398, 2012. 
[155] C. W. Shields, C. D. Reyes, and G. P. López, “Microfluidic cell sorting: a review of the advances in the separation of cells from debulking to rare cell isolation.,” Lab Chip, vol. 15, no. 5, pp. 1230–49, 2015. 
[156] T. J. Maguire, E. Novik, P. Chao, J. Barminko, Y. Nahmias, M. L. Yarmush, and K.-C. Cheng, “Design and Application of Microfluidic Systems for In Vitro Pharmacokinetic Evaluation of Drug Candidates,” Curr Drug Metab, vol. 10, no. 10, pp. 1192–1199, 2009. 
[157] L. Kim, Y.-C. Toh, J. Voldman, and H. Yu, “A practical guide to microfluidic perfusion culture of adherent mammalian cells.,” Lab Chip, vol. 7, no. 6, pp. 681–694, 2007. 
[158] J. Atencia and D. J. Beebe, “Controlled microfluidic interfaces.,” Nature, vol. 437, no. 7059, pp. 648–655, 2005. 
[159] D. M. Bissell, D. M. Arenson, J. J. Maher, and F. J. Roll, “Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver,” J. Clin. Invest., vol. 79, no. 3, pp. 801–812, 1987. 
[160] G. a Hamilton, S. L. Jolley, D. Gilbert, D. J. Coon, S. Barros, and E. L. LeCluyse, “Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions.,” Cell Tissue Res., vol. 306, no. 1, pp. 85–99, 2001. 
[161] J. C. Dunn, M. L. Yarmush, H. G. Koebe, and R. G. Tompkins, “Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration.,” FASEB J., vol. 3, no. 2, pp. 174–7, 1989. 
[162] E. L. LeCluyse, K. L. Audus, and J. H. Hochman, “Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration.,” Am. J. Physiol., vol. 266, no. 6 Pt 1, pp. C1764–74, 1994. 
[163]  et al Liu X, Brouwer KL, Gan LS, Brouwer KR, Stieger B, Meier PJ, “Partial maintenance of taurocholate uptake by adult rat hepatocytes cultured in a collagen sandwich configuration.pdf,” Pharm. Res., vol. 15, pp. 1533–9, 1998. 
[164] M. Maurice, E. Rogier, D. Cassio, and G. Feldmann, “Formation of plasma membrane domains in rat hepatocytes and hepatoma cell lines in culture.,” J. Cell Sci., vol. 90 ( Pt 1), pp. 79–92, 1988. 
[165] J. Riedl, K. C. Flynn, A. Raducanu, F. Gärtner, G. Beck, M. Bösl, F. Bradke, S. Massberg, A. Aszodi, M. Sixt, and R. Wedlich-Söldner, “Lifeact mice for studying F-actin dynamics.,” Nat. Methods, vol. 7, no. 3, pp. 168–169, 2010. 
[166] L. Ritsma, E. J. a Steller, S. I. J. Ellenbroek, O. Kranenburg, I. H. M. Borel Rinkes, and J. van Rheenen, “Surgical implantation of an abdominal imaging window for intravital microscopy.,” Nat. Protoc., vol. 8, no. 3, pp. 583–94, 
   124
2013. 
[167] J. Schindelin, I. Arganda-carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld, B. Schmid, J. Tinevez, D. J. White, V. Hartenstein, K. Eliceiri, P. Tomancak, and A. Cardona, “Fiji : an open-source platform for biological-image analysis,” vol. 9, no. 7, 2012. 
[168] Y. Liu, Y. Hu, and L. Huang, “Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.,” Biomaterials, vol. 35, no. 9, pp. 3027–34, 2014. 
 
   125
Appendix 
 Figure A. 1 Manufacturing volume on different materials [Reprinted from http://www.fikst.com/pubs/DeviceMfgNewsletter.pdf with no permission requirements on the website] [17] 
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